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ABSTRACT
Self-Efficacy, Trait Mindfulness, and Self-Compassion as Predictors of Risk of Substance Use
Relapse
Jonathan Nauser, M.S.
Previous research has demonstrated relationships among mindfulness, self-efficacy, and
substance use relapse. Contrasting research has found mindfulness and self-efficacy are not
consistently negatively associated with substance use relapse demonstrating a need for further
research. An additional factor that has been found to associated with substance use is selfcompassion; however, it has yet to be examined in relation to the process of relapse. The current
study assessed self-efficacy, self-compassion, and mindfulness and their associations with
substance use relapse, with the aim of predicting relapse risk. Higher levels of relapse risk were
found to be negatively associated with self-efficacy, trait mindfulness, and self-compassion.
Additionally, through a hierarchical regression, self-efficacy was found to significantly predict
relapse risk. After adding trait mindfulness into the regression model, significantly more variance
was explained for relapse risk. However, when self-compassion was added into the model, it was
found to be still predictive of relapse risk but did not add a significant amount of variance to the
model. Findings suggest that individuals with higher levels of self-compassion, self-efficacy and
trait mindfulness are less likely to relapse while in recovery from substance use. The current
study’s findings indicate these three variables play a role in substance use relapse and have
potential to be utilized in integrated relapse prevention treatments. Implications for substance use
programs and integrated treatments are discussed, as well as strengths and limitations of the
study and suggestions for future research.
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CHAPTER 1: INTRODUCTION AND LITERATURE REVIEW
Substance use has and continues to be a pervasive problem within society. The number of
individuals with substance use disorders that return to using their substance of choice ranges
from 70 to 80% (Brandon, Vidrine, & Litvin, 2007; Miller, Westerberg, Harris, & Tonigan,
1996; Walton, Blow, Bingham, & Chermack, 2003). Although substance use relapse is still
considered to be common in the process of recovery, extant research is still not able to fully
explain the contributing factors in a relapse. Moreover, the definitions of relapse vary in
complexity and detail. For example, Hunt, Barnett, and Branch (1971) defined relapse as a return
of the problem behavior, whereas other researchers defined relapse as a static, discrete, or end
state (Donovan, 1996; Marlatt, 1985; Miller, 1996). Regardless of how relapse is defined, Polivy
and Herman (2002) stated that for individuals who attempt to change their behavior in a certain
direction, lapses will occur that often lead to relapse. Given the large frequency of relapse for
individuals recovering from substance use disorders, it is evident that the issue has persisted
across decades and research is needed to understand this complex process. The occurrence of
relapse has costly effects for those trying to recover from a substance use disorder (SUD) their
families and society.
Statement of the Problem
The problem of substance use affects multiple different areas of our society, such as the
prison system, the workforce, and healthcare. Regarding the economic cost of caring for those
with a substance use disorder, the National Institute on Drug Abuse (NIDA, 2017) reported more
than $740 billion was spent on substance use-related concerns related to crime, lost work
productivity, and health care as of 2017. Substance use has not only had a dramatic economic
effect, but it also has cost the lives of thousands within the United States. In 2010, there were an
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estimated 40,000 drug overdose deaths involving cocaine or opioids and, most recently, the
number of drug overdose deaths involving those specific substances has more than doubled
(NIDA, 2017). In 2016, there were some estimated 64,000 drug overdose deaths with just over
20,000 of those attributed to the sharp increase in deaths related to fentanyl and fentanyl analogs
(NIDA, 2017). The prevalence of using an illicit substance has also increased over time. As of
2013, an estimated 24.6 million Americans 12 years of age or older (9.4% of population) have
used an illicit drug in the past month (NIDA, 2015). This prevalence statistic has increased by a
full percent of the population since 2002 (NIDA, 2015). The Center for Disease Control (CDC)
estimated that 114 people die per day of drug overdoses and an estimated 6,748 people will be
sent to hospital emergency rooms for treatment per day as well (Rudd, Seth, David, & Scholl,
2016). A separate statistic from the Substance Abuse and Mental Health Services Administration
(SAMHSA) found that 90% of people who needed substance use treatment did not receive it.
Given these recent statistics, it is evident substance use has been and continues to be an ongoing
issue in society which demands numerous resources and continued effort to sustain recovery.
One method to combat addiction is by understanding what propels the addictive process as well
as what factors interrupt recovery and lead into relapse. The current research identifies variables
that have been associated with substance use relapse in previous literature and explores another
variable that possibly plays a role in this process.
Current literature identifies mindfulness (Appel & Kim-Appel, 2009; Bowen & Enkema,
2014; Fernandez, Wood, Stein, & Rossi, 2010; Karyadi, VanderVeen, & Cyders, 2014; Leigh,
Bowen, & Marlatt, 2005; Leigh & Neighbors, 2009; Robinson, Ladd, & Anderson, 2014) and
self-efficacy (Ilgen, McKellar, & Moos, 2007; Ilgen, McKellar, & Tiet, 2005; Ilgen, Tiet,
Finney, & Moos, 2006; Moos & Moos, 2006; Trucco, Connery, Griffen, & Greenfield, 2007) as
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contributing factors in relapse, but with mixed results. Research has indicated that mindfulness is
negatively related to alcohol use (Fernandez et al., 2010), severity of dependence (Bowen &
Enkema, 2014), and lifetime alcohol and marijuana use in clinical samples (Robinson et al.,
2014); however, other studies have found that mindfulness has been positively correlated with
heavy substance use (Leigh et al., 2005; Leigh & Neighbors, 2009). Other researchers, such as
Burling, Reilly, Moltzen, and Ziff (1989) found self-efficacy levels to be higher in abstainers
than those who relapse in their substance use, but self-efficacy was not predictive of positive
treatment outcome in a follow-up interview. Other self-efficacy research has found self-efficacy
evaluations to be predictive of successful abstinence (DiClemente, 1986). Ilgen et al. (2005) and
Ilgen et al. (2006) also added significant mixed findings in the relationship between self-efficacy
and relapse. Ilgen et al. (2005) found that self-efficacy was not always predictive of abstinence
after a year follow-up, while Ilgen et al. (2006) found that self-efficacy was a strong predictor of
a larger percent of abstinent days in one year when combined with a strong therapeutic alliance.
Researchers have just begun to examine the related construct of self-compassion in
relation to substance use (Brooks, Kay-Lambkin, Bowman, & Childs, 2012; Miron et al., 2014;
Rendon, 2007; Tanaka et al., 2011; Vettese et al., 2011), but have not explored self-compassion
as a predictor of relapse risk. The proposed study will assess self-efficacy, self-compassion, and
mindfulness and their associations with substance use relapse, with the aim of predicting relapse
risk.

Relapse
Since the 1970s, research has been conducted in efforts to operationalize and define what
constitutes a substance use relapse (Hunt, Barnett, & Branch, 1971; Marlatt & George, 1984;
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Miller, 1996). Behavioral research has defined relapse as any return to the problem behavior
(Hunt et al., 1971), whereas those who practice within the medical model have defined relapse as
a discrete or single event (Marlatt & George, 1984; Miller, 1996). Marlatt and George (1984)
broadened the terminology and defined relapse as a dynamic process that ultimately results in a
return to previous behavior patterns. For the purposes of this investigation, relapse will be
examined as more of a dynamic process that involves many internal and external issues (Brown,
Vik, & Creamer, 1989; El, Gaily, El, & Bashir, 2004; Ramo, Anderson, Tate, & Brown, 2005;
Uslaner, Kalechstein, Richter, Ling, & Newton, 1999). This definition was chosen for this
investigation due to the purposeful examination of internal factors.
Previous investigators have tried to answer the question as to why those recovering from
addiction relapse back into substance use and continue this pattern of behavior. Scholars in this
field have often attributed the event to internal triggers, such as depressive symptoms (Uslaner et
al., 1999), conflict/life stress, negative emotional states, and active emotional states (Caselli,
Ferretti, Leoni, Rebecchi, Rovetto, & Spada, 2010; Ramo et al., 2005). The internal triggers that
contribute to substance use relapse were explored by Uslaner et al. (1999). The researchers
recruited 17 cocaine-dependent men to be assessed for psychiatric symptoms on an addiction
severity index via a brief symptom inventory during a 14-day inpatient substance use recovery
program. Participants with higher depression scores were more likely to report feelings of
failure, anhedonia, guilt, self-hatred, self-blame, indecisiveness, low motivation, and fatigue. In
this study, these symptoms appeared to be associated with the high induced by cocaine and
subsequent discontinuation of the drug, and supported to be possible indicators for a relapse.
Uslaner et al. (1999) specifically focused on cocaine dependent men, limiting the application of
their findings to broader populations with various addictions other than cocaine dependence.
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External triggers linking to substance use relapse include situational factors (e.g., socializing
with others abusing substances, individuals’ reported most important person abstaining from
drugs and alcohol, social environment) (Brown, Vik, & Creamer, 1989), testing personal control,
social pressure, urge and temptations (El, Gaily, El, & Bashir, 2004).
Another population that was examined for contributors of relapse included adolescents
diagnosed with alcohol and other drug dependencies (Brown et al., 1989). In this qualitative
study, the researchers identified the circumstances of adolescent relapse to clarify any
differences between adult and adolescent relapse to develop treatment programs for teens.
Researchers obtained consent from 75 adolescents and their parents to participate in a structured
interview regarding sociodemographic, medical, psychiatric, and drinking and drug use
information for the adolescent and his or her family. These same adolescent participants were
assessed three months and six months posttreatment. Areas that were assessed included alcohol
and drug use during the follow-up period, physical, social, and interpersonal characteristics of
initial relapse experiences, and functioning in major life areas. One third of relapsed adolescents
in this study reported that they were attempting to cope with a negative affective state (16.7%
depression, 13.3% anger/frustration, and 3.3% other) at the time of the relapse (Brown et al.,
1989). Negative affective states have been found to be significant pre-cursors to relapse in adults
and adolescents; however, depression is a complicated emotional state that warrants further
analysis of what specific symptoms of depression are related to relapse. The previously
mentioned research highlights not only the importance of situational factors in the contribution
of relapse, but also highlights the importance of other contributing factors being currently
researched, such as internal issues and active emotional states at the time of relapse.
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Previous studies have shown that there are differences and similarities between
populations in terms of pre-cursors to relapse, both internally and externally. Ramo et al. (2005)
examined a different population of adolescents with comorbid psychiatric disorders and factors
associated with the relapse process for substance use. They aimed to clarify the role of
psychiatric symptom severity and situational self-efficacy in a population of youth in a substance
use treatment program. Adolescents receiving inpatient treatment for alcohol and other SUDs
along with a co-occurring diagnosed disorder were selected to participate in a Contextual Cue
Assessment for Relapse interview within the first six months following treatment. This interview
assessed interpersonal, intrapersonal, and other contextual information related to the relapse
episode. Self-efficacy was also measured using a questionnaire that assessed coping self-efficacy
in relation to adolescent risk for relapse situations. In their findings, self-efficacy and psychiatric
symptoms both significantly predicted relapse following a conflict/life stress experience and
negative emotional states (Ramo et al., 2005). Taken together, these results suggest that
adolescents with limited self-efficacy and present comorbid psychiatric symptoms appeared most
vulnerable to relapse in circumstances characterized by conflict/life stress and negative
emotional states. From Ramo et al. (2005), not only are situational factors strong precursors for
relapse in adolescents, but characteristics, such as self-efficacy, appear to be also.
El et al. (2004) found congruent findings with Ramo et al.’s (2005) study in their
examination of the role of self-efficacy in relapse, specifically measuring differences between
participants addicted to alcohol and heroin across relapse dimensions. A sample of 105
individuals with substance use disorders within Al-Amal hospital in Jeddah, Saudi Arabia were
given two self-report questionnaires that assessed for the clients’ high-risk situations for alcohol
and other drug relapse and their ability to cope with these high-risk situations in everyday life.
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For participants that identified as having an alcohol use disorder, results were found to be nonsignificant in terms of differences in their self-efficacy in high-risk situations for relapse,
whereas participants who identified as heroin addicts were found to have poorer self-efficacy
levels to resist urge in social and peer interactions (El et al., 2004). These mixed results suggest
further research is needed into how self-efficacy contributes to relapse, and what other factors
might play a role in relapse as well. From the previous findings, it is a fair assumption to state
that believing in one’s self and one’s performance can serve to protect someone from relapse.
A separate examination sought to determine the predictive value of rumination in
predicting the absence or presence of alcohol use (Caselli et al., 2010). A sample of 80 outpatient
participants were administered a battery of questionnaires including the Ruminative Responses
Scale of the Responses Styles Questionnaire, which measured the tendency to ruminate in
response to depression. Depression, rumination, and alcohol consumption level were measured
before the first treatment session, and drinking status and level of alcohol use were assessed at
three, six, and 12-month follow ups. It was found that rumination had higher predictive power
for drinking status compared to baseline alcohol use and baseline depression in the three, six, and
12-month follow ups (Caselli et al., 2010). Further correlational analyses found that higher levels
of rumination were found to be positively correlated with level of alcohol use following
treatment (Caselli et al, 2010).
The previously reviewed research regarding relapse illustrates that there are multiple
contributing factors to this complex process. Situational factors such as socializing with others
abusing substances (Brown et al., 1989) play a significant role as well as internal factors
(Uslaner et al., 1999). Negative affective states (Brown et al., 1989), rumination (Caselli et al.,
2010), and self-efficacy (El et al., 2004; Ramo et al, 2005) have also been found to key
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motivators to relapse. However, the current research intends to clarify the predictive role of selfefficacy in relapse risk. Prior to demonstrating other internal factors’ roles in relapse, significant
factors must be discussed in their utility of relapse prevention.
Relapse Prevention Models
Cognitive-behavioral treatment interventions are commonly used within relapse
prevention models. Marlatt and Gordon (1985) conceptualized relapse to include cognitive,
behavioral, and affective mechanisms underlying the process. The authors also conceptualized
addiction as stemming from maladaptive habit patterns rather than solely physiological responses
to the addictive substance (Marlatt & Gordon, 1985). From this conceptualization of addiction
and relapse, Marlatt and Gordon (1985) suggested that relapse prevention occurs at a critical
stage of the habit; specifically, after initial cessation of substance use. In support of the relapse
prevention model, Moos and Finney (1983) found that a significant portion of the variability
associated with the long-term effectiveness of substance use treatment was related to
environmental factors after completion of formal treatment. In addition, the relapse prevention
model seeks to provide individuals with coping strategies to prevent a "slip" from progressing
into a full-blown relapse. If these coping strategies are not developed and practiced, the model
asserts that beliefs and expectations regarding a lapse may influence continued use (Moos &
Finney, 1983).
Throughout time and research, relapse prevention methods have been called into question
regarding their efficacy (Irvin, Bowers, Dunn, & Wang, 1999; Witkiewitz & Marlatt, 2004). As a
result, other treatment models for substance use and relapse being suggested (Drake, Wallach, &
McGovern, 2005; Witkiewitz, Marlatt, & Walker, 2005) and tested (Bowen et al., 2009). To
examine the relapse prevention model’s efficacy, Irvin et al. (1999) conducted a meta analytic
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review of 26 studies to evaluate the effectiveness of Marlatt and Gordon’s (1985) relapse
prevention model in comparison to other active interventions (e.g., physician advice,
psychoeducation). When compared to active interventions, relapse prevention was found to have
few differences overall in comparison of effectiveness; additionally, the meta-analysis found that
relapse prevention was less effective for some substances (e.g., cocaine use, cigarette smoking)
(Irvin et al. 1999). Overall results indicated that relapse prevention was effective across
substance of addiction, treatment setting, and in comparison to other treatment modalities (Irvin
et al., 1999). However, it was found in the meta-analysis that relapse prevention had more of an
effect in improving psychosocial functioning than on reducing substance use (Irvin et al., 1999).
Along with Irvin et al.’s (1999) calling the efficacy of relapse prevention into question,
Witkiewitz and Marlatt’s (2004) article proposed a reconceptualized cognitive-behavioral model
of relapse that increases focus on the interactions between risk factors and situational
determinants. In conjunction with Irvin et al.’s (1999) meta-analysis results, Witkiewitz and
Marlatt (2004) provided literature supporting relapse prevention as more effective than no
treatment and as equally effective as other treatment interventions (e.g., supportive therapy and
interpersonal therapy). Along with their overview of relapse prevention effectiveness, the authors
also suggested improving relapse prevention with a model that focuses on situational dynamics.
Witkiewitz and Marlatt (2004) proposed future research in relapse prevention models to include
self-efficacy, outcome expectancies, motivation, craving, coping, and emotional states variables.
To supplement relapse prevention techniques, Witkiewitz and Marlatt (2004) suggested other
treatments (e.g., mindfulness meditation) for addictive behaviors be implemented.
Accompanying the suggested improvements of relapse prevention (Irvin et al., 1999;
Witkiewitz & Marlatt, 2004), Drake et al. (2005) stated current approaches to relapse prevention
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emphasize cognitive aspects and minimize biological and socioenvironmental aspects. This
minimization renders relapse prevention more effective for individuals without severe mental
disorders. This suggests using the same relapse prevention model for individuals with and
without severe mental disorders may be inadequate (Drake et al., 2005). The cognitive and social
deficits in individuals with severe mental illness (e.g., brain reward systems, self-medication) can
be expected to reduce the effectiveness of learning new skills and can lead to isolation and
victimization. Therefore, these findings illustrate that general relapse prevention models are not
effective across all populations that are treating substance use and need to be revised to provide
efficacious treatment for individuals across different populations with differing needs.
Following Witkiewitz and Marlatt’s (2004) suggestion of using an adjunctive treatment
with relapse prevention, Witkiewitz et al. (2005) described a new approach to drug and alcohol
addiction using Mindfulness-Based Relapse Prevention (MBRP). MBRP is implemented as an
intervention combining mindfulness meditation with cognitive-behavioral skills training for
addiction and is designed to reduce the risk and severity of relapse following substance use
treatment (Bowen, Chawla, & Marlatt, 2010; Witkiewitz et al., 2005). Witkiewitz et al. (2005)
demonstrated that traditional relapse prevention is not effective for every individual with SUD.
Witkiewitz et al. (2005) stated that little is known about the moderators and mediators of relapse
prevention’s effectiveness. It has been argued that there are cognitive (e.g., self-efficacy, craving,
motivation) and behavioral mechanisms of change (e.g., contingencies, coping) that mediate and
moderate the effectiveness of relapse prevention (Witkiewitz & Marlatt, 2004) and that an
underlying premise of these mechanisms is a focus on the present moment, acceptance, and
nonjudgmental understanding (Witkiewitz et al., 2005). Mindfulness meditation is suggested to
further enhance relapse prevention interventions for problematic substance use behavior based
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on the previously mentioned mechanisms that often go unaddressed. The goal of MBRP is to
develop awareness and acceptance of thoughts, feelings, and sensations through practicing
mindfulness as a way to cope with cravings and triggers for relapse (Witkiewitz et al., 2005).
Bowen et al. (2009) conducted the first randomized controlled trial of MBRP and compared it to
an outpatient 12-step relapse prevention program.
Bowen et al. (2009) assessed the treatment effects of MBRP on substance use outcome as
well as associated processes such as craving, mindfulness, and acceptance. The authors
hypothesized that participation in MBRP would be associated with greater reductions in
substance use, and greater increases in acceptance and mindfulness compared to treatment as
usual (Bowen et al., 2009). Treatment as usual was operationalized as a 12-step, process-oriented
format that included topics of rational thinking skills, grief and loss, assertiveness, self-esteem,
goal setting, and related themes. After an eight-week period of MBRP or a continuation of
treatment as usual for eight weeks, participants then completed follow up assessments.
Significant decreases were found in overall days of substance use, craving, and significant
increases were found in levels of awareness and acceptance post-intervention among participants
in the MBRP condition compared to participants in the treatment as usual condition (Bowen et
al., 2009). However, these gains appeared to diminish four months after the interventions had
concluded, returning to similar levels of the treatment as usual condition. This diminishment
suggests further maintenance is required past an eight-week intervention to maintain levels of
acceptance, awareness, and craving. Bowen et al. (2009) suggested the reduction in craving
severity in their study may be explained by increased levels of awareness of sensations, thoughts,
and emotions that accompany craving in combination with the encouragement of acceptance and
nonreactivity to the craving response. The authors further discussed that with repeated exposure
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to craving triggering stimuli and the continued practice of nonreactivity, this may result in the
forming of a habit over time, thereby decreasing the intensity of a craving sensation (Bowen et
al., 2009).
To further add strength to the use of MBRP, recent research into this intervention (Bowen
et al., 2014; Roos, Bowen, & Witkiewitz, 2017; Witkiewitz, Bowen, Douglas, & Hsu, 2013) has
found effectiveness when compared to treatment as usual (Bowen et al., 2014) and has been
associated with lower levels of craving (Witkiewitz et al., 2013). In addition, studies have found
that MBRP is effective for preventing relapse in populations with severe SUDs and symptoms of
depression and anxiety (Roos et al, 2017; Zemestani & Ottaviani, 2016). Witkiewitz et al. (2013)
examined the follow-up effects of MBRP on post-treatment craving scores and self-reported
changes in craving during and following MBRP. Findings included that MBRP was associated
with significant reduction in craving during and following MBRP (Witkiewitz et al., 2013).
Specifically, the results showed that acceptance, awareness and nonjudgment significantly
mediated the relationship between MBRP and self-reported levels of craving following the
intervention (Witkiewitz et al., 2013). When compared to treatment as usual and cognitivebehavioral relapse prevention, MBRP has produced significantly lower relapse risk up to 12months posttreatment (Bowen et al., 2014).
Another example of MBRP and its efficacy in substance use relapse prevention is its use
for individuals with dual diagnosis (Roos et al., 2017; Zemestani & Ottaviani, 2016). Roos et al.
(2017) compared the efficacy of MBRP to cognitive-behavioral relapse prevention models
among participants recruited from a substance use treatment agency. Participants were assessed
for substance use over a 12-month period, SUD symptom severity, and depression and anxiety
symptoms. MBRP was found to have a significant main effect on participants with high SUD
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symptom severity, high depression, and anxiety symptoms (Roos et al., 2017). MBRP was also
found to have a significant main effect on participants with high SUD symptoms severity, low
depression, and anxiety symptoms in number of alcohol and drug use days (Roos et al., 2017).
The results indicate MBRP may be more effective for clients with co-occurring high SUD
symptom severity and high levels of depression and anxiety symptoms, and for clients with high
SUD symptom severity and no presenting depression or anxiety symptomology (Roos et al.,
2017). However, the findings also indicate that among clients with relatively less severe SUD
symptoms, depression, and anxiety symptoms, there may be no significant differences in
treatment effects with MBRP, cognitive-based relapse presentation, or treatment as usual (Roos
et al., 2017), suggesting that other possible factors may be contributing to relapse occurrence,
and that other treatments may be more effective for individuals with less severe pathology.
Similarly, Zemestani and Ottaviani (2016) investigated differences in reductions in
cravings between participants in an inpatient setting receiving treatment as usual or MBRP.
Participants receiving MBRP reported significant differences between pre- and post-treatment;
specifically, differences were found through improvements in depression and anxiety symptoms,
as well as craving symptoms when compared to participants in the treatment as usual condition
(Zemestani & Ottaviani, 2016). These findings are relevant due to the increased risk for relapse
amongst depressed individuals with co-occurring substance use disorders (Brown et al., 1989;
Uslaner et al., 1999), suggesting further factors related to depression may be contributory to
relapse. Similar to Zemestani and Ottaviani’s (2016) research, Zgierska, Rabago, Chawla,
Kushner, Koehler, and Marlatt (2009) found congruent results in their review of the existing
literature on mindfulness-based interventions for SUDs.
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Zgierska et al. (2009) conducted a systematic review of the existing evidence on
mindfulness-based interventions for SUDs. Overall, 50-85% of the reviewed studies showed a
positive outcome when mindfulness-based interventions were introduced to substance use
affected subjects, compared to baseline conditions or other therapy. Additionally, data collected
from controlled studies indicate that participants receiving mindfulness-based interventions do as
well or better than participants receiving other therapy or pharmacotherapy alone in terms of
maintaining sobriety (Zgierska et al., 2009). The current proposal intends to improve upon these
methodologies by comparing the variance explained through mindfulness and other constructs in
predicting substance use relapse amongst individuals recovering from SUDs.
Further strengthening the utility of mindfulness in the proposed study, Bowen et al.
(2006) and Brewer et al. (2009) examined the use of mindfulness in reducing the amounts of
substances used across different drugs. Bowen et al. (2006) found that the use of a mindfulnessbased treatment in an incarcerated population was related to reductions in alcohol, marijuana,
and crack cocaine use. Additionally, Brewer et al. (2009) added feasibility to mindfulness
training after comparing the practice to cognitive behavioral therapy in reducing stress reactivity
in substance use patients. Their findings indicated that mindfulness training was just as effective
in reducing stress reactivity as cognitive behavioral therapy in this specific population, indicating
that these practices would promote abstinence and prevention of relapse. It is evident from the
previously mentioned research that the trait of mindfulness is valued in the prevention of
substance use relapse, but this literature also suggests there is room for other variables to be
explored in their relation to substance use relapse. The current proposal aims to examine selfcompassion in its relation to relapse due to its relationship to mindfulness (Neff, 2003; 2004),
and its inclusion of other cognitive and affective processes that have been found to be related to
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continued substance use (Brooks, Kay-Lambkin, Bowman, & Childs, 2012; Miron et al., 2014;
Rendon, 2007; Tanaka, Wekerle, Schmuch, Paglia-Boak, & MAP Research Team, 2011;
Vettese, Dyer, Li, & Wekerle, 2011).
Relapse prevention has been found to have few differences overall in comparison of
effectiveness to other treatment interventions (Irvin et al. 1999) but has been shown to be more
effective than no treatment and equally as effective as other interventions (Witkiewitz &
Marlatt,2004). A separate relapse prevention intervention, MBRP, adds the component of
mindfulness in the treatment of SUD and has been found to be associated with significant
decreases in overall days of substance use and craving compared to treatment as usual (Bowen et
al., 2009; Bowen et al., 2014; Witkiewitz et al., 2013). MBRP’s utility in different populations
has also been demonstrated in preventing relapse in populations with severe SUDs and
symptoms of depression and anxiety (Roos et al, 2017; Zemestani & Ottaviani, 2016). However,
past research also suggests that other possible factors may be contributing to relapse occurrence,
and that other treatments may be more effective for individuals with less severe pathology
(Brown et al., 1989; Uslaner et al., 1999). The current proposal intends to improve upon these
methodologies by comparing the variance explained through mindfulness and other constructs in
predicting substance use relapse amongst individuals recovering from SUDs. The role of
mindfulness in the process of relapse must be further examined before comparisons with other
factors are made.
Mindfulness
A separate variable in the proposed research is trait mindfulness. There are varying
definitions of mindfulness across research, but a common theme across all definitions is that
mindfulness is a way of directing attention and being aware. Mindfulness is conceptualized as a
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state of consciousness integrating self-awareness and attention with personality characteristic of
being open, welcome, and non-judgmental (Brown & Ryan, 2003; Kabat-Zinn, 1990; Segal,
Williams, & Teasdale, 2002). Brown and Ryan (2003) defined mindfulness as also consisting of
increased awareness and attention in present reality or current activity. Being mindful requires
the awareness and focus on current experience, which involves concentrating on behavior that is
out of conscious awareness (e.g., breathing) and attention (Kabat-Zinn, 1990; Segal et al., 2002).
Brown and Ryan (2003) found that state mindfulness was positively associated with several
dimensions of wellbeing (e.g., optimism, positive affect, self-actualization) and negatively
associated with components of psychological and emotional disturbance (e.g., negative affect,
depression, anxiety, rumination). Additionally, they found that state mindfulness predicted selfregulation and positive emotional states (Brown & Ryan, 2003).
Mindfulness has also been examined in its relation to substance use and relapse (Appel &
Kim-Appel, 2009; Bowen & Enkema, 2014; Fernandez, Wood, Stein, & Rossi, 2010; Garland,
Boettiger, Gaylord, Chanon, & Howard, 2011; Garland, Roberts-Lewis, Kelley, Tronnier, &
Hanley, 2014; Karyadi & Cyders, 2015; Leigh, Bowen, & Marlatt, 2005; Leigh & Neighbors,
2009; Robinson, Ladd, & Anderson, 2014; Shorey, Anderson, & Stuart, 2014; Shorey et al.,
2013; Shorey, Brasfield, Anderson, & Stuart, 2015). Throughout this past decade, mindfulness
has been suggested to have a significant role in the development, treatment, and recovery from
substance use and addiction, but research supporting this has been hampered by methodological
issues and requires further study (Appel & Kim-Appel, 2009). The construct of mindfulness has
been presented with mixed findings in connection with substance use. In some studies,
mindfulness has been found to be negatively related to alcohol use (Fernandez et al., 2010),
severity of dependence (Bowen & Enkema, 2014), and lifetime alcohol and marijuana use in
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clinical samples (Robinson et al., 2014); however, other studies found that mindfulness has been
positively correlated with heavy substance use (Leigh et al., 2005; Leigh & Neighbors, 2009).
These mixed findings have led to the proposed study to further examine the prediction of relapse
by trait mindfulness. The current proposal intends to add further study of the relationship
between trait mindfulness, substance use, and addiction in a population of individuals recovering
from SUDs.
Leigh et al. (2005) found a positive relationship between mindfulness scores and frequent
binge-drinking behavior. Leigh and Neighbors (2009) followed up these findings by evaluating
the mediating factors of coping and enhancement motives on the relationship between
mindfulness and alcohol consumption among college students. They found that greater
mind/body awareness was associated with more alcohol use in a non-clinical population of men
and women (Leigh & Neighbors, 2009). Contrasted with these positive associations of
mindfulness and substance use behavior are findings of negative associations between
mindfulness and substance use in clinical samples (Bowen & Enkema, 2014; Fernandez et al.,
2010; Robinson, Ladd, & Anderson, 2014).
Fernandez et al. (2010) predicted mindfulness to be inversely related to both alcohol use
and negative consequences due to alcohol in a population of 316 students at a mid-sized
Northern public university. Through structural equation modeling, the authors found negative
associations between alcohol use and the mindfulness sub-scales of “acting with awareness” and
“describe” (Fernandez et al., 2010). Similarly, Robinson et al. (2014) found mindfulness to be
negatively associated with a likelihood of lifetime alcohol or marijuana use. The aim of their
study was to better understand the impact of mindfulness on substance use within the context of
impulsivity. Baseline mindfulness was found to be a significant predictor of lifetime abstinence
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from marijuana and alcohol use in high school students (Robinson et al., 2014). The relatively
low intensity of substance use within the sample limited the generalization of the results to
individuals who use more heavily and use other substances, suggesting the relationship between
mindfulness and substance use requires further examination. Bowen and Enkema (2014) sought
to explore the relationship between substance use and mindfulness further by predicting a
negative relationship between mindfulness and dependence severity in a clinical sample.
Analyses assessed the relationship between trait mindfulness and severity of substance
dependence in an adult clinical population, to provide further data on this relationship in clinical
versus nonclinical populations. Results suggested a negative relationship between mindfulness
and severity of dependence in treatment-seeking adults with SUD (Bowen & Enkema, 2014).
Further analyses of the subscales of the mindfulness measure revealed significant negative
relationships between substance dependence severity and the mindfulness factors of acting with
awareness, describing, and nonjudgment (Bowen & Enkema, 2014).
Another example of inconsistent findings regarding the relationship between mindfulness
and substance use is provided through a meta-analysis by Karyadi, VanderVeen, and Cyders
(2014). The authors aimed to quantify the relationship between mindfulness and substance use
behaviors, and to examine how the relationship varies across mindfulness facets and substance
type. Potential moderators of the relationship were also examined in exploratory analyses and
included sample characteristics (e.g., clinical status, gender, age, and race) and substance use
severity (e.g., problematic vs. non-problematic substance use behaviors). A small but significant
negative correlation was found in the relationship between mindfulness and substance use
behaviors; however, this relationship varied across substance used, clinical status of participants,
and substance use severity (Karyadi et al., 2014). Exploratory results indicated a more robust
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negative relationship between mindfulness and substance use for alcohol use and tobacco use
disorders, problematic SUDs, and with inpatient clinical samples (Karyadi et al., 2014). The
results of this conflicting research indicate further examination of mindfulness in relation to
substance use needs to be continued along with its relationship to substance use relapse. The
relapse prevention models that have been previously mentioned need to be specific in the
treatment of substance use and maintenance of abstinence, but also need to be broadened to
capture the entire SUD population, which implies that more variables need to be considered in
relapse prevention such as trait mindfulness.
Kiken, Garland, Bluth, Palsson, and Gaylord (2015) defines trait mindfulness as one’s
predisposition to be mindful in daily life. Deepening the examination of the association between
trait mindfulness and substance use, Garland et al. (2011) hypothesized that alcohol dependent
individuals with higher levels of trait mindfulness would possess less attentional bias toward
visual cues of alcohol compared to individuals with lesser levels of trait mindfulness. Trait
mindfulness was found to be inversely associated with alcohol attentional bias, perceived stress,
and subjective alcohol craving among individuals recovering from alcoholism (Garland et al.,
2011). These results can be taken to mean that trait mindfulness relates to the disengagement of
attention from alcohol cues, strengthening resistance against alcohol relapse and dependence.
Repetitively engaging, disengaging, and moving attention away from alcohol cues towards
beneficial stimuli is suggested to weaken associative networks of alcohol use action schemas and
strengthen an alcohol dependent person’s ability to avoid relapse (Garland et al., 2011).
Although these results provide insight into how trait mindfulness plays a role in
refraining from substance use or relapse, it is necessary to inquire if trait mindfulness also plays
a role into whether an individual seeks substance use treatment. An example of this additional
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role of trait mindfulness is provided through Shorey et al. (2013) and their examination of
differences in trait mindfulness between adult substance users who sought residential treatment
and in healthy, non-clinical adults. Greater deficits were found in individuals with substance
users disorders seeking treatment compared to healthy adults in terms of trait mindfulness
(Shorey et al., 2013). Specifically, individuals seeking treatment were found to have deficits in
the trait mindfulness factors of curiosity and decentering as compared to healthy adults. Since the
participants in the Shorey et al. (2013) study seem to be engaging in more healthy stimuli by
seeking substance use treatment, but have deficits in certain areas of trait mindfulness, these
findings are somewhat contradictory to Garland et al. (2011). Further research is needed to
examine levels of trait mindfulness in those maintaining abstinence and those at high risk for
relapse.
Specific factors of trait mindfulness have been found to be associated with various factors
of substance use (Bowen & Enkema, 2014; Fernandez et al., 2010; Garland et al., 2011; Shorey
et al., 2013), but further research is mentioned linking mindfulness to specific factors of relapse
such as craving (Garland et al., 2014) and maladaptive schemas (Shorey, Anderson et al., 2015;
Shorey, Brasfield, et al., 2015). Garland et al. (2014) explored the possible mediators of the
relationship between trait mindfulness and substance craving. Substance craving is defined as a
sense of dysphoria or anxiety coupled with unpleasant somatic sensations that may impel an
individual with a SUD to engage in substance use as a means of satiating the craving (Garland et
al., 2014). First an inverted relationship was found between trait mindfulness and substance
craving that was partially mediated by negative affect and reappraisal (Garland et al., 2014).
These findings suggest that individuals in recovery from SUDs that possess higher levels of trait
mindfulness may be less vulnerable to cravings because they are better able to downregulate
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distressing emotions and reappraise the meaning of life’s challenges. Mindfulness is associated
with craving in substance relapse, while additional research (Anderson et al., 2015; Shorey,
Brasfield, et al., 2015) has found mindfulness to be related to a separate factor of relapse,
maladaptive schema.
Shorey, Brasfield, et al. (2014) stated that substance use may be a form of avoidant
behavior to cope with the remains of early maladaptive schemata. Since this relationship has
been established, the authors examined the relationship between early maladaptive schemas and
trait mindfulness in a sample of men seeking substance use treatment. They hypothesized that
trait mindfulness would be negatively associated with early maladaptive schemas, and
individuals who endorsed multiple maladaptive schemata would report lower trait mindfulness
compared to individuals who endorse fewer early maladaptive schemata (Shorey, Brasfield, et
al., 2015). The findings indicated that the majority of maladaptive schemata were negatively
associated with trait mindfulness. The researchers also found that individuals who endorsed
multiple maladaptive schemata evidenced lower levels of trait mindfulness compared to
individuals with one or no early maladaptive schemata (Shorey, Brasfield, et al., 2015). Thus, the
presence of early maladaptive schemata likely represents a lack of ability to be present and
centered due to increased interactions between negative cognitive beliefs and maladaptive
behaviors such as substance use. These findings are consistent with other research involving the
maladaptive schemata factors of substance use and trait mindfulness.
For example, Shorey, Anderson, et al. (2015) also examined the relationship between trait
mindfulness and early maladaptive schemata in a sample of women in residential substance use
treatment. Like Shorey, Brasfield, et al. (2015), Shorey, Anderson, et al. (2015) hypothesized
that trait mindfulness would be negatively associated with early maladaptive schema and that
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individuals with greater maladaptive schema endorsement would report lower trait mindfulness
compared to individuals with less early maladaptive schema endorsement. Findings
demonstrated that the majority of early maladaptive schemata were negatively associated with
trait mindfulness in the sample of women seeking substance use treatment (Shorey, Anderson, et
al., 2015). The findings also confirmed the authors’ second hypothesis, that women with more
than one early maladaptive schema reported lower trait mindfulness than women with one or no
maladaptive schemata (Shorey, Anderson, et al., 2015). These combined findings represent a
distinct factor of substance use that could be targeted in treatment to reduce the risk of relapse
using the skill of mindfulness.
Further supporting the relationship between trait mindfulness and other factors
contributing to substance use relapse, Karyadi and Cyders (2015) narrowed the scope in their
examination of the relationship between trait mindfulness, alcohol cravings, and alcohol use
behaviors. Specifically, the authors examined how trait mindfulness and its facets differentially
related to separate alcohol use behaviors and how the relationships between trait mindfulness and
alcohol use behaviors might be mediated by cued alcohol cravings (Karyadi & Cyders, 2015).
Trait mindfulness was found to be negatively associated with only problematic alcohol use, but
not with alcohol quantity or duration of use (Karyadi & Cyders, 2015). Additionally, cued
alcohol cravings were found to be supported as the possible mechanism through which trait
mindfulness and acting with awareness influence alcohol use (Karyadi & Cyders, 2015). This
suggests that individuals who specifically have higher levels of acting with awareness stand to be
at lower risk for developing problematic levels of alcohol use by reducing the effect of alcohol
cues on alcohol cravings.
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Taken together, mindfulness has been positively associated with several dimensions of
well-being and negatively associated with components of psychological and emotional
disturbance (Brown & Ryan, 2003). Specifically, mindfulness has been found to be related to
alcohol use (Fernandez et al., 2010), severity of dependence (Bowen & Enkema, 2014), and
lifetime alcohol and marijuana use in clinical samples (Robinson et al., 2014), but with mixed
results (Bowen & Enkema, 2014; Fernandez et al., 2010; Karyardi et al., 2014; Leigh et al.,
2005; Leigh & Neighbors, 2009; Robinson et al., 2014). The trait of mindfulness has also been
found to be in deficit for individuals seeking substance use treatment (Shorey et al., 2013) and
has been linked to specific factors of relapse such as craving (Garland et al., 2014), maladaptive
schemas (Shorey, Anderson et al., 2015; Shorey, Brasfield, et al., 2015), and problematic use
(Karyadi & Cyders, 2015). However, further research is needed to examine differences in trait
mindfulness for those maintaining abstinence and for those at more risk for relapse and to
address other possible factors of substance use and relapse that are underrepresented in the
variability explained by trait mindfulness. In efforts to better understand the process of substance
use relapse, mindfulness and other personal factors need to be compared to one another in their
predictability of relapse, such as self-compassion and self-efficacy.
Self-Compassion
The conceptualization of self-compassion can be rooted to Buddhist philosophy and has
been used to better understand the development of healthy self-attitudes (Leary et al., 2007; Neff,
2003; Neff 2004). Neff (2003) defined and examined self-compassion in relation to other
psychological constructs (e.g., coping, emotion regulation, mental well-being, self-esteem, selfpity) and linked the concept to overall psychological functioning. Self-compassion involves
being open to one’s own suffering, building the desire to relieve one’s suffering, and healing
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oneself with kindness (Neff, 2003). Neff (2003) broke down self-compassion into three separate
components: a) self-kindness, b) common humanity, and c) mindfulness. Self-kindness is defined
as the extension of kindness and understanding to oneself rather than harsh judgement and selfcriticism. Common humanity is defined as seeing one’s experiences as part of the larger human
experience rather than perceiving these events as separating and isolating. The third component
of mindfulness is defined as holding one’s own painful thoughts and feelings in balanced
awareness rather than over-identifying with them. Although substantial research has been done
examining the relationship between self-compassion and substance use (Miron et al., 2014;
Tanaka, Wekerle, Schmuch, Paglia-Boak, & MAP Research Team, 2011; Vettese, Dyer, Li, &
Wekerle, 2011), and self-compassion’s correlation with levels of depression, anxiety, and
substance use (Brooks, Kay-Lambkin, Bowman, & Childs, 2012; Rendon, 2007), the value of
self-compassion in predicting substance use relapse has not been extensively studied or
compared with other valuable predictors.
The construct of self-compassion was introduced in efforts to better define the concept of
a healthy relationship and attitude with oneself. Although previous research has indicated that
self-efficacy is an optimal measure for such a relationship (El et al., 2004; Ramo et al., 2005), an
alternative concept possibly better suited for the population of substance users is selfcompassion. The population of individuals in recovery from substance use disorders has
exhibited hatred and negative attitudes toward themselves, leading to more frequent relapse
behaviors (Brown et al., 1989; Ulsaner et al., 1999). These findings open the possibility of selfcompassion being a beneficial area of development within the process of recovery for those
suffering from substance use.
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The examination of self-compassion is differentiated from self-pity in that when a person
experiences self-pity, the person becomes consumed with their own problems and forgets that
others are experiencing similar issues; self-compassion allows one to see their relatable
experiences and others’ experiences without the disconnection (Neff, 2003). In a separate
overview of self-compassion by Neff (2004), a distinction was made between self-compassion
and self-esteem. Self-esteem is defined as our sense of self-worth, perceived value, or how much
we like ourselves, whereas Neff (2004) stated that self-compassion is not based on selfevaluations or set standards. Within self-esteem, people feel love and kindness toward
themselves based on traits or talents, compared to feeling love and kindness because they are
human beings deserving of such compassion. Neff (2004) later reviewed research that has linked
self-compassion to other indicators of healthy psychological functioning. Neff has previously
found high levels of self-compassion to be associated with lower levels of neuroticism, anxiety,
depression, rumination, and greater life satisfaction (Neff, 2004). Neff, Kirkpatrick, and
Dejitthirat (2004) found self-compassion to be positively associated with problem-focused
coping strategies and adaptive emotion-focused strategies, such as reframing one’s issues in a
positive manner, while also being negatively associated with maladaptive coping strategies, such
as denial (as cited in Neff, 2004). Leary et al. (2007) also examined how people with low vs.
high self-compassion respond to negative events. The five studies summarized consisted of 523
undergraduate college students reporting negative events in their daily lives, responding to
hypothetical scenarios, reacting to interpersonal feedback, providing ratings of their or others’
videotaped performances in an awkward situation, and reflecting on negative personal
experiences. Participants high in self-compassion were more likely to accept responsibility for
their role in negative events in their daily lives and attribute the cause of these negative events to

ROLES IN RELAPSE RISK

26

the type of person they were (Leary et al., 2007). Self-compassionate people were less likely to
ruminate on their negative evaluations by others and less likely to ruminate on their negative
affect when confronted by their transgressions (Leary et al., 2007). These findings are taken
together to “suggest that self-compassionate people more readily accept undesirable aspects of
their character and behavior than people low in self-compassion without obsessing about them,
becoming defensive, or feeling badly” (Leary et al., 2007, p. 901). From the examinations of
self-compassion, it is evident that this concept is definable, measurable, and linked to several
factors associated with healthy psychological functioning.
Self-esteem was further distinguished from self-compassion by how people react to
negative events in daily life. Participants high in self-esteem responded to negative events in
their daily lives with more defensiveness, rumination, and negative affect compared to
participants high in self-compassion (Leary et al., 2007). These results provide further validity to
the construct of self-compassion. Additionally, correlations between factors of psychological
well-being and self-compassion, and predictive value of more positive cognitions following
negative events, strengthen the validity of the construct. However, there is little research
demonstrated for self-compassion to be predictive of positive outcomes in clinical populations
recovering from substance use disorders, therefore leaving an avenue for self-compassion
research to be conducted.
When recovering from addiction, a sense of motivation for abstinence must be present.
Depression is reported to be at high levels within recovery and relapse (Uslaner et al., 1999),
along with motivation being simultaneously reported to be low in both recovery and relapse. In
relation to self-compassion, Breines and Chen (2012) concluded that if an individual performs
practices of self-compassion, they will have a greater drive to improve their personal weaknesses
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or moral transgressions. These results can be broadened into the population of recovering
substance use addicts; specifically, higher levels of self-compassion can increase the drive to
improve the longevity of abstinence from illicit substances. A gap in the literature exists as to
what internal characteristic can lessen the maladaptive processes that lead to relapse, thereby
forming a research question asking if self-compassion a predictor of substance use relapse risk
and be developed of strengthened to increase chances of sustained recovery. To strengthen the
plausibility of using self-compassion to predict substance abuse relapse risk, characterizations of
relapse must be shown to be negatively associated with self-compassion.
Substance use relapse can be a continuous cycle that is characterized by interpersonal
conflict (Ramo et al., 2005) and urges or temptations (El et al., 2004). Perhaps a method of
preventing relapse is treating the stepping stones to relapse rather than just treating the general
problem of addiction. Self-compassion has been introduced as an intervention to reduce
interpersonal conflict (Yarnell & Neff, 2013). The authors hypothesized that individuals higher
in self-compassion are more likely to compromise their personal needs when conflicts occurred
in their relationships. College students were recruited to write a real-life example of a conflict
they had with either their father, mother, best friend, or romantic partner. Afterwards, the 506
participants completed an emotional turmoil rating for the conflict and an assessment of wellbeing within the relationship context. Finally, participants were assessed on their levels of selfcompassion. The hypotheses were supported across the four relational contexts of mother, father,
best friend, and romantic partner. Self-compassionate individuals were more likely to resolve
their relationship conflicts in a manner that balances the needs of themselves and the needs of
others (Yarnell & Neff, 2013). This means that people higher in self-compassion were
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significantly more likely to resolve relational conflicts rather than lessen their personal needs or
to assert priority of their needs over others (Yarnell & Neff, 2013).
In terms of substance use and self-compassion’s association, self-compassion has been
found to be negatively associated with maltreatment backgrounds (e.g., child abuse), while these
backgrounds were found to be positively associated with alcohol problems in the same results
(Miron et al., 2014). Similar research has also found that adolescents with low self-compassion
were more likely to experience alcohol use problems and other maltreatment-related impairments
compared to adolescents with higher self-compassion (Tanaka et al., 2011). Finally, Vettese et al.
(2011) found that participants’ self-compassion levels were significantly and uniquely predictive
of addiction severity. Although these results derive relationships among self-compassion,
likelihood of developing substance use problems, and addiction severity, no further analyses or
speculations are made of the directionality of the relationship between specific variables related
to substance use.
In summarizing the literature relating self-compassion to substance use, it has been found
that self-compassion is positively associated with positive coping strategies, while also being
negatively associated with maladaptive coping strategies (Neff et al., 2004). Individuals with
high levels of self-compassion were more likely to accept responsibility for their role in negative
events and less likely to ruminate on negative affect (Leary et al., 2007). Self-compassion has
also been found to be linked to other factors associated with substance use, such as moral
transgressions (Breines & Chen, 2012) and reduction of interpersonal conflict (Yarnell & Neff,
2013). Within research relating self-compassion and substance use specifically, it has been found
to be negatively associated with maltreatment backgrounds which were previously positively
associated with alcohol problems (Miron et al., 2014). Different levels of self-compassion have
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been found to be related to problematic alcohol use experiences (Tanaka et al., 2011) and
addiction severity (Vettese et al., 2011). To date, little research has linked self-compassion to
outcomes of recovery from substance use disorders. A gap in the literature that the current
proposal intends to close is the existence of self-compassion’s role in relapse risk when
compared against other known factors (e.g., trait mindfulness, self-efficacy) that relate to relapse
in substance use recovery.
Self-Efficacy
Self-efficacy is the final variable that will be considered in the proposed research. Selfefficacy has been established as a predictor of substance use relapse while contended against
other predictor variables (Ilgen, McKellar, & Moos, 2007; Ilgen, McKellar, & Tiet, 2005; Ilgen,
Tiet, Finney, & Moos, 2006; Moos & Moos, 2006; Trucco, Connery, Griffen, & Greenfield,
2007). Albert Bandura conceptualized self-efficacy in 1977 and defined it as confidence in one’s
own abilities to achieve intended results (Bandura, 1977). Self-efficacy beliefs have been found
to determine how people think, feel, motivate themselves and act in social settings. These beliefs
produce diverse effects through the major processes of cognition, motivation, affect and selection
(Bandura, 1993). Other research regarding self-efficacy has shown the influential power it has on
thought patterns, actions, and emotional arousal (Bandura, 1982). Perceived self-efficacy has
been shown to account for “changes in coping behavior influenced by level of physiological
stress reactions, self-regulation of behavior, resignation and despondency to failure experiences,
self-debilitating effects of proxy control and illusory inefficaciousness, achievement strivings,
growth of intrinsic interest, career pursuits…” (Bandura, 1982, p. 122). This means that an
individual with a higher perception of self-efficacy has less stress, higher self-regulation
behaviors, less personalization of failures, higher frequencies of relinquishing control, higher
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acts of striving for achievement, internal interest, and pursuits of a career. However, research has
indicated that self-efficacy and self-compassion are related and “because research on selfcompassion is relatively new, studies that examine the relationships between self-compassion
and psychological variables such as self-efficacy…are needed” (Iskender, 2009, p. 713).
Although very little research has been conducted comparing the predictability among
self-compassion, self-efficacy, and mindfulness, some researchers have argued that self-efficacy
(Bandura, 1999; Burling, Reilly, Moltzen, & Ziff, 1989; DiClemente, 1986), mindfulness
(Bowen et al., 2006; Brewer et al., 2009; Leigh, Bowen, Marlatt, 2005), and self-compassion
(Miron, et al., 2014; Tanaka, Wekerle, Schmuch, Paglia-Boak, & MAP Research Team, 2011;
Vettese, Dyer, Li, & Wekerle, 2011) are connected to substance use. The connection between
self-efficacy and substance use has mixed findings. Burling, Reilly, Moltzen, and Ziff (1989)
found contrary findings to the literature at the time, with their results of self-efficacy levels being
higher in abstainers than those who relapse in their substance use, but self-efficacy was not
related to the rates of relapse in a follow-up interview. However, DiClemente (1986) found that
self-efficacy evaluations predicted successful abstinence. DiClemente (1986) originally sought to
explore the role of self-efficacy in the process of addictive behavior change, specifically the
stages of maintenance and cessation for a variety of addictive behaviors such as smoking,
alcoholism, and over-eating. The results of his exploration found that participants’ self-efficacy
evaluations demonstrated value in discriminating which participants were likely to experience a
relapse and which participants were likely to succeed in sustaining sobriety (DiClemente, 1986).
Although DiClemente’s (1986) study provided support to the construct of self-efficacy having a
role in substance use relapse, there was little exploration into whether these results varied for
those with differing drug addictions. El et al. (2004) found participants with alcoholism had a
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higher mean rating of self-efficacy in high-risk relapse situations compared to participants with a
heroin addiction. The differences in self-efficacy among persons addicted to alcohol or heroin
were attributed to a variety of factors, including a negative evaluation by community increasing
the sense of inferiority and humiliation, thereby leading to lower self-efficacy (El et al., 2004).
The current proposal suggests there are other factors such as self-compassion that may account
for this sense of inferiority and humiliation and can be utilized as an additional predictor to
substance use relapse in those recovering from SUDs.
Since El et al.’s (2004) research has utilized self-efficacy in predicting relapse during
high-risk situations, self-efficacy has also been utilized in efforts to predict abstinence one year
after SUD treatment (Ilgen, McKellar, & Tiet, 2005). Participants were administered a battery of
measures after detoxification from abusing substances and prior to the beginning of treatment,
discharge, and 1-year follow up from their SUD treatment. Among the measures of substance use
and confidence in high-risk relapse situations, an additional measure of general self-efficacy for
abstinence was included in the battery. Ilgen et al.’s (2005) results add significant mixed findings
in the relationship between self-efficacy and relapse. Not every participant with high abstinence
self-efficacy was abstinent from their drug of choice at the 1-year follow up (Ilgen et al., 2005).
These findings also suggest that self-efficacy may not be as potent of a predictor of relapse and
abstinence and indicates that other factors need to be considered in treatment when relapse
occurs. They also suggest that there are several variables that are included in the process of
relapse, and examining one predictor is not enough to account for total variance. Self-efficacy
was also predicted to be a factor that interacts with therapeutic alliance in relation to 1-year
alcohol use-disorder outcomes (Ilgen et al., 2006). Participants were 785 individuals with a
diagnosis of alcohol use-disorder and were assessed on three separate occasions during their
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outpatient treatment at a substance use treatment facility. They were assessed on drinking
behavior, alcohol abstinence self-efficacy, and working alliance. Ilgen et al. (2006) found that
self-efficacy and a stronger therapeutic alliance predicted better 1-year alcohol related outcomes,
specifically a larger percent of abstinent days in one year. Although this further provides strong
evidence for the use of self-efficacy in predicting abstinence in alcohol use-disorder, Ilgen et
al.’s (2006) findings also indicate there are possible and underlying or separate factors that are of
benefit when predicting a relapse. The methodology also leaves out self-efficacy in predicting
abstinence within populations with differing types of addiction, furthering the need for literature
to be added that examines these unknown factors and relationships. The current proposal intends
to explore self-efficacy’s role in the maintenance of recovery not only amongst those with
alcohol use disorder, but with other SUDs as well.
The relationship between self-efficacy and abstinence has also been examined. Ilgen et al.
(2007) examined predictors of self-efficacy 12 months after discharge from a SUD treatment.
The predictors included patient characteristics at baseline, frequency of alcohol or drug use,
alcohol/drug problems, psychiatric symptoms, substance use-specific coping, and confidence in
abstinence. Participants completed the battery of assessments at intake to SUD treatment and at
1-year follow-up. Self-efficacy was found to be a product of both patient-specific attributes and
behaviors and experiences during treatment (Ilgen et al., 2007). No treatment orientation was
associated with higher self-efficacy at the 1-year follow-up assessment, which indicates that selfefficacy is largely related to a combination of pre-existing cognitive and behavioral patterns and
skills learned during the participants’ treatment (Ilgen et al., 2007). These findings indicate that
general treatment for SUDs influences a patient’s self-efficacy rather than a specific treatment
orientation (e.g., Alcoholics Anonymous, 12-Step, cognitive-behavioral, therapeutic
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community). Treatment was considered as exposure to specific factors uniquely associated with
greater self-efficacy such as coping skills and stress-management (Ilgen et al., 2007). Additional
factors uniquely associated with self-efficacy that would be able to better predict the risk of
relapse need to be further examined to investigate possible missing factors that influence the
relationship between substance abstinence and internal factors.
More recently, Kelly and Greene (2014) examined the predictive utility of self-efficacy
on substance use outcome along with a contingent factor of motivation for sobriety, and the
interaction between self-efficacy and motivation. Participants were assessed based on alcohol
and other drug use, abstinence self-efficacy and motivation for recovery at baseline, end of
treatment, and three, six, and 12 months post-discharge. Through hierarchical modeling Kelly
and Greene (2014) found that each variable alone is an independent statistically significant and
moderately strong predictor of substance use. Also, there was a significant relationship found
among these variables, indicating that one variable is dependent on the other. Findings included
that for patients high in self-efficacy, the level of an individual’s motivation made a statistically
significant difference to their outcome over time, with “lower motivation pulling down percent
of days abstinent despite the high confidence” (Kelly & Greene, 2014, p. 7). For patients low in
self-efficacy, the level of motivation made a significant difference, with high motivation making
a positive impact in percent of days abstinent (Kelly & Greene, 2014). Taken together, these
findings indicate that highly motivated patients may be able to maintain higher levels of
abstinence more successfully than those with low motivation.
Much like the previous research mentioned regarding mindfulness and substance use, the
literature regarding self-efficacy and substance use is mixed. When combined with other
variables accounting for abstinence, self-efficacy has been found to predict successful abstinence
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(DiClemente, 1986; Ilgen et al., 2006), indicating other underlying factors have separate roles
from self-efficacy when predicting a relapse. In contrast with these findings, high abstinence
self-efficacy has not always been found to be predictive of abstinence itself (Burling et al., 1989;
Ilgen et al., 2005) and that this variable is not always a powerful predictor of abstinence
regardless of drug of choice (El et al., 2004). Due to these mixed findings, there is a current need
for studies examining the association between self-efficacy and substance use relapse. Additional
research is also needed to examine the relationships between self-efficacy and other
psychological variables such as self-compassion (Iskender, 2009). Although mindfulness, selfcompassion, and self-efficacy have been found to be related to substance use and relapse, these
constructs have not been examined together. The current proposal intends to broaden upon Kelly
and Greene’s (2014) research, in comparing self-compassion, self-efficacy, and mindfulness in
predicting substance use relapse, using hierarchical modeling.
Rationale
Prior research demonstrates that relationships among mindfulness, self-efficacy, and
substance use relapse do exist. However, mindfulness and self-efficacy have not been
consistently found to be negatively associated with substance use relapse (Burling, Reilly,
Moltzen, & Ziff, 1989; Leigh, Bowan, & Marlatee, 2005) and self-compassion has only been
utilized to predict addiction severity rather than relapse (Vettese et al., 2011), which raises the
need for further research. The purpose of the proposed study is to examine self-compassion, selfefficacy, and mindfulness and their association to substance use relapse. Four hypotheses will be
tested in this dissertation.
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Research Hypotheses
Hypothesis 1: The relationship between self-compassion (Self-Compassion Scale-Short
Form; SCS-SF) and substance use relapse risk (Advanced Warning of Relapse Measure;
AWARE) will be significantly negatively correlated in a sample of individuals recovering from
addiction. A Pearson Product-Moment correlation will be conducted to assess the relationship
between SCS-SF scores and AWARE scores.
Hypothesis 2: The relationship between self-efficacy (Drug Avoidance Self Efficacy
Scale; DASES) and substance use relapse risk (AWARE) will be significantly negatively
correlated in a sample of individuals recovering from addiction. A Pearson Product-Moment
correlation analysis will be conducted to assess the relationship between DASES scores and
AWARE scores.
Hypothesis 3: The relationship between mindfulness (Five Facet Mindfulness
Questionnaire – Short Form; FFMQ-SF) and substance use relapse risk (AWARE) will be
significantly negatively correlated in a sample of individuals recovering from addiction. A
Pearson Product-Moment correlation analysis will be conducted to assess the relationship
between FFMQ-SF scores and AWARE scores.
Hypothesis 4: In addition to the variance explained in relapse risk (AWARE) by selfefficacy (DASES), and mindfulness (FFMQ-SF), there will be a positive impact and an
incremental explanation of variance by self-compassion (SCS-SF) in a sample of individuals
recovering from addiction. Participants who score lower levels of self-compassion, self-efficacy,
and mindfulness will be predicted to have higher substance use relapse risk. A hierarchical
multiple regression analysis will be conducted to assess the relationship between SCS-SF scores,
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CHAPTER 2: METHODS

Participants
Participants in the current study consisted of individuals recovering from substance use
disorders. A multiple regression analysis with one degree of freedom and three total predictors
was entered into G*Power (Faul, Erdfelder, Buchner, & Lang, 2009), indicating a minimum
sample size of 77 participants to find an existing medium effect. The Institutional Review Board
(IRB) was informed that the study would limit the sample size to a maximum of 100 participants,
which is similar to previous research on this topic. Participants were recruited from outpatient
substance use treatment services at Chestnut Ridge Center, Lakewood Center, the residential
treatment program Center for Hope and Healing and the intensive outpatient program. All are
WVU Medicine treatment programs. The sampling of participants was conducted using a
purposive sampling method. Inclusion criteria of the proposed sample consisted of having a preexisting diagnosis of any varied substance use disorder and being at least 18 years of age.
Participation was not restricted based on sexual orientation, race, or ethnicity. Exclusion criteria
for participants included a diagnosis of a non-substance-based addiction (e.g., gambling, sex,
video games), younger than the age of 18, and not having a pre-existing diagnosis of a substance
use disorder.
Measures
Drug Avoidance Self-Efficacy Scale (DASES, Martin, Wilkinson, & Poulos, 1995).
For the current study, self-efficacy was measured in individuals recovering from substance use
using the DASES (Martin et al., 1995; Appendix A). The DASES is a 16-item measure which
assesses self-efficacy for addictive behaviors that is applicable to individuals engaged in both
single substance use and poly-substance use. The measure uses a response scale from 1 (certainly
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no) to 9 (certainly yes). Higher scores indicate higher drug avoidance self-efficacy. Items 2, 4, 7,
8, 10, 11, 12, and 16 are reverse coded. A total score is computed. A sample item from this
measure includes “Imagine that a new job is starting tomorrow, you are going out with friends
and expecting a good time. Could you resist the urge to celebrate with drugs?”. This variable was
used as a predictor variable.
Martin et al. (1995) examined the construct validity by exploring this via convergent and
divergent validity. The researchers found a consistent pattern of convergent and discriminant
validity among the DASES items. Convergent and discriminant validity were assessed by
examining the association of pretreatment self-efficacy with 15 variables related to drug use
severity and duration along with measures of personality factors. Self-efficacy to avoid relapse
was most strongly associated with factors that could impact confidence to avoid drug use in the
future, providing convergent validation. Discriminant validity was found through a lack of
association with individual or personality factors. In terms of construct validity, it was evaluated
on a subset of the sample and was found to be evident in significant correlations with existing
measures of differential rates of changes in self-efficacy associated with two types of treatment,
and with similar measures of drug use severity. The correlations ranged from .26 to .66, which
were all statistically significant (Martin et al., 1995). Cronbach’s alpha for the overall scale was
.91 and was not been improved by deleting any of the 16 items. Split-half reliability was assessed
using two separate types of analyses. Using the Spearman-Brown analysis, the split-half
reliability was found to be .90 and using the Guttman analysis, the split-half reliability was found
to be .87 (Martin et al., 1995). Cronbach's alpha for the current sample was 0.921 which is
acceptable (Taber, 2017).
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Five Facet Mindfulness Questionnaire-Short Form (FFMQ-SF, Bohlmeijer, ten
Klooster, Fledderus, Veehof, & Bohlmeijer, 2011). Trait mindfulness in individuals recovering
from substance use was assessed using the FFMQ-SF (Bohmeijer al., 2011; Appendix B). The
FFMQ-SF is a 24-item measure which assesses the five facets of trait mindfulness: observing,
describing, acting with awareness, non-judging, and nonreactivity to inner experience. The
measure uses a Likert-response scale from 1 (never or very rarely true) to 5 (almost always or
always true). Higher scores indicate higher mindfulness. Items 4, 5, 7, 8, 11, 12, 14, 17, 19, 22,
23, and 24 are reverse scored. This measure yields a total score. A sample item from this
measure includes “I’m good at finding the words to describe my feelings.” This variable was
used as a predictor variable.
Bohlmeijer et al. (2011) examined the content validity with confirmatory factor analyses
and by relating the FFMQ to measures of psychological symptoms, well-being, experiential
avoidance, and the personality factors neuroticism and openness to experience. Confirmatory
factor analyses showed good model fit for a correlated five-factor structure of the FFMQSF. The replicability of the five-factor structure of the FFMQ-SF was confirmed in a separate
sample of participants. Five-factor models of the FFMQ demonstrated acceptable fit, where the
correlated five-factor model (Bohlmeijer et al., 2011). This finding confirms that the FFMQ
measures five distinct but related aspects of mindfulness, which can also be considered facets of
an overall mindfulness factor.
To demonstrate convergent and discriminant validity, Pearson correlation coefficients
were calculated between FFMQ facets and other constructs (e.g., Acceptance and Action
Questionnaire-II, NEO Five-Factor Inventory, Hospital Anxiety and Depression Scale, Center
for Epidemiological Studies Depression Scale, Mental Health Continuum-Short Form), and were
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found to be moderately or strongly related (convergent validity) or weakly or not related
(discriminant validity) to mindfulness (Bohlmeijer et al., 2011). Reliability of the FFMQ facets
were assessed with Cronbach’s alpha coefficients. All facets of the FFMQ demonstrated
adequate internal consistency reliability, with alpha coefficients of .75 for non-reactivity to inner
experience, .81 for observe, .83 for acting with awareness, .83 for non-judging of inner
experience, and .87 for describing (Bohlmeijer et al., 2011). Additionally, the facets were
moderately intercorrelated (r’s ranged from .15 to .41), indicating that the facets measure related,
but sufficiently distinct, aspects of mindfulness. Cronbach’s alpha for the current sample was
.82, which is robust (Taber, 2017).
Self-Compassion Scale-Short Form (SCS-SF, Raes, Pommier, Neff, & Van Gucht,
2011). Self-compassion in individuals recovering from substance use was assessed by using the
SCS-SF (Raes et al., 2011; Appendix C). The SCS-SF is a 12-item measure shortened from the
self-compassion scale (SCS; Neff, 2003) which assesses the kindness and understanding toward
the self in instances of pain or failure rather than being self-critical; the perception of one’s
experiences as part of the larger human experience rather than seeing them as unique to the self;
and the possession of painful thoughts and feelings in mindful awareness rather than overidentifying with the maladaptive thoughts. The measure uses a Likert-response scale ranging
from 1 (almost never) to 5 (almost always). Higher scores indicate higher levels of selfcompassion. Items 1, 4, 8, 9, 11, and 12 are reverse scored. Raes et al. (2011) examined the
internal consistency reliability of the SCS-SF using a confirmatory factor analysis for each of the
subscales. The confirmatory factor analysis demonstrated that the shortened SCS has the same
higher-order factor structure as the original full scale with a ‘general’ higher-order selfcompassion factor and six second-order factors corresponding to the six facets of self-
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compassion: self-kindness, self-judgment, common humanity, isolation, mindfulness and overidentification. The internal consistency reliability coefficient for the SCS-SF total score is .86.
The correlation between the total score of the long and short form was near perfect, r = 0.97
(Raes et al, 2011). With these correlations and internal consistency estimates, it is reasonable to
state the SCS-SF has good reliability (Raes et al., 2011).
Content validity of the original self-compassion scale (SCS) was examined by asking
participants who they tended to be kinder to, themselves or others, expecting those with higher
self-compassion would tend to say that they were equally kind to self and others, while those
with low self-compassion would tend to say that they were kinder to others than to themselves.
Within the assessment of content validity, convergent and divergent validity were assessed by
including other established measures that assessed related constructs such as self-criticism, social
connectedness, and emotional intelligence. To establish the content validity, individuals with
higher self-compassion levels were found to be equally kind to the self and others, whereas
individuals with lower self-compassion were found to be kinder to others than to themselves
(Neff, 2003). With respect to the construct validity, self-compassion scores were found to have a
significant negative correlation with the construct of self-criticism (-.65), and a significant
positive correlation with the construct of social connectedness (.41). The results of these validity
and reliability assessment studies support the validity and psychometric soundness of the SCSSF (Neff, 2003). A sample item from this measure includes, “I try to see my failings as part of
the human condition.” This measure yields on total score and was treated as a predictor variable.
Cronbach's alpha for the current sample was 0.778, which is fairly high (Taber, 2017).
Advanced Warning of Relapse Scale (AWARE, Miller & Harris, 2000). Relapse risk
in individuals recovering from substance use disorders was assessed using the AWARE Scale
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(Miller & Harris, 2000; Appendix D). The AWARE Scale is a 28-item measure that was
designed as a measure of the warning signs of relapse. The measure uses a Likert-type response
scale ranging from 1 (never) to 7 (always). The higher the score, the more warning signs of
relapse are being reported. Items 8, 14, 20, 24, and 26 were reverse scored prior to computing
participant total scores. A total score was yielded. A sample item from this measure includes “I
think about using substances.” Wording on items 1, 26, and 28 will be amended to apply to
individuals that use alcohol and/or drugs. For example, item 1 states, “I feel nervous or unsure of
my ability to stay sober.” This item was amended to read “I feel nervous or unsure of my ability
to stay clean of alcohol and/or drugs.”
Miller and Harris (2000) examined the stability of scores over time of the AWARE by
computing two indices of reliability. Internal consistency of the 28-item scale was high at both
baseline and 12 months with alpha coefficients of .91 and .93, respectively (Miller & Harris,
2000). Test-retest reliability was also assessed to determine the stability of the AWARE scale
over a two-month period. The test-retest correlation for the overall AWARE scale was .80
(Miller & Harris, 2000). With these correlations and internal consistency ratings, it is reasonable
to state the AWARE scale has good test-retest and internal consistency reliability. Predictive
validity was examined by asking participants about their slip and relapse status at each follow-up
point every two months post-treatment and were predicted by discriminant function analysis,
entering first the client's drinking status at the prior interview. Then client's AWARE score from
two months earlier was entered to determine whether the scale accounted for significant variance
beyond that associated with prior drinking to demonstrate that AWARE still predicted both slip
and relapse status at subsequent follow-up points. Harris and Miller (2000) found that AWARE
scores still predicted both slip and relapse status. The AWARE scale has been found to have
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strong convergent validity with measures of symptom severity (Kelley, Hoeppner, Urbanoski, &
Slaymaker, 2011) and with measures of alcoholism and other measures designed to predict
relapse (Harris & Miller, 2000). Discriminant validity has been established by demonstrating a
lack of statistically significant correlations with family substance use history, negative life
experience, and motivation for change (all r’s < 0.03) (Harris & Miller, 2000). Only Pearson
values of 0.40 or higher were reported (in this sample, r = 0.34 would be the threshold for p <
.001, which is the Bonferroni corrected alpha value). The results of these validity and reliability
assessment studies support the validity and reliability of the AWARE scale. This variable was
treated as a criterion variable. Cronbach’s alpha for the current sample was 0.911 which is strong
(Taber, 2017).
Substance Use Relapse and Demographics. A brief eight-item demographics
questionnaire (Appendix E) was included in the measures. The demographics measured included
the nominal variables of sex, race, and ethnicity, along with the continuous variable of instances
having relapsed. Questions related to substance use relapse was also assessed within this same
questionnaire. Assessment questions regarding substance use relapse included questions of drug
of choice, number of times in substance use treatment, and number of times having relapsed on
any substance in the past six months. The demographics questionnaire defined relapse as having
sustained some days of sobriety prior to using an illicit substance or alcohol. These data were
used as controls in the regression analyses.
Procedures
Following a full board review by the university’s Institutional Review Board (IRB),
participants were recruited from outpatient, group-based treatment programs for opioid use
disorder using Medication Assisted Therapy (MAT) developed at West Virginia University as
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well as the Center for Hope and Healing, and an intensive outpatient program. Participants were
recruited from the pre-existing, group-based treatment program using sampling methodology. To
ensure the protection of the participants’ rights, no identifying information was linked to their
provided data. Participants were informed about their right to drop out of the study and their
right to refuse to participate. Additionally, participants were informed about the duration of the
study and the necessary instructions for completion of the battery of questionnaires. Each
participant that agreed to participate in the study were rewarded one of 100 $5.00 Sheetz gift
cards. If participants withdrew before the end of the study, they were not awarded a gift card. If
participants successfully completed the study, they were awarded one of 100 $5.00 Sheetz gift
cards, and it was given to them once they turn in the completed forms.
Upon entering a provided quiet room in each substance use clinic, participants were given
recruitment (Appendix E) letters and informed consent forms (Appendix F) explaining their
rights as participants in a psychological study, the right of refusal, an explanation of risks and
possible discomfort, and an opportunity to withdraw their data without negative consequence.
The primary researcher, and a Chestnut Ridge Center employed research assistant received
consent only when the participant understood the procedures and when the participant signed the
consent form. Once the consent process had been completed, the collection of data began with
the administration of the questionnaire packet. The paper questionnaire packet along with a
writing utensil was presented to each participant. The measures were distributed in random order
(counterbalanced) to prevent order effects. The questionnaires provided included the SCS-SF
(Neff, 2003b), the FFMQ-SF (Bohlmeijer et al., 2004), the DASES (Martin et al., 1995), the
AWARE (Miller & Harris, 2000) and finally a demographics questionnaire assessing substance
use relapse. Each questionnaire was preceded with written instructions for completion. Once all
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questionnaires were completed, the participant was provided with post-study information
regarding the nature of the study. The post-study information included a description of the study.
Participants were informed that their contact information will not be linked to their responses to
maintain the anonymity of their data.
Design and Analysis
Descriptive statistics were calculated, and data was assessed for normality prior to
conducting the analyses. Data assessment for assumptions included obtaining an adequate
sample size for four independent variables entered into the analysis. Also, the assumption of
singularity was met as the independent variables (Drug Avoidance Self-Efficacy, Trait
Mindfulness, and Self-Compassion) were not to be a combination of other independent variables.
An examination of correlations was conducted to assess for an assumption of multicollinearity
among independent variables. Other assumptions that were tested for normality of data included
assumptions of normality, linearity, and homoscedasticity. If assumptions were not met, caution
was expressed in the interpretation of significance and effect size. Descriptive statistics were
then presented along with the internal consistency reliabilities for each of the instruments used.
The first three hypotheses were tested using Pearson’s r, the collected data from each
participant’s packet were analyzed through hierarchical multiple regression using the SPSS
statistical package for Windows (I.B.M. Corp, 2010). The analysis specifically analyzed the
magnitude and direction of the relationship between the variables of the explained variance in
self-reported substance use relapse risk on the AWARE and among the three predictor variables
of the FFMQ-SF, SCS-SF, and DASES. The hierarchical regression analysis was conducted by
entering the constructs’ total scores for each participant in a theoretical rank order based on
previous literature for explaining the variance in the criterion variable of substance use relapse
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risk (AWARE). Models of comparison were made by adding variables to each previous model to
compare the proportion of explained variance in substance use relapse rates. The covariate of
amount of time in treatment was controlled in the regression model. Data were kept in a secure
storage compartment under lock and key; data will be kept for five years after the completion of
the study, and then it will be shredded and destroyed.
The current study was a descriptive correlational design with three predictor variables
and one criterion variable. The predictor variables were self-compassion scores on the SCS-SF
(Neff, 2003b), mindfulness scores on the FFMQ-SF (Bohlmeijer et al., 2004), and self-efficacy
scores on the DASES (Martin et al., 1995). The criterion variable was substance use relapse risk,
which was assessed using the AWARE (Miller & Harris, 2000). Each participant’s scores on the
predictor variables served to predict the rate of participants’ substance use relapse risks. The
hierarchical regression analysis was conducted by the researcher entering in participant total
scores on the DASES, FFMQ-SF, and SCS-SF in a theoretical rank order for explaining the
variance in the criterion variable of substance use relapse measured by the AWARE construct.
Models of comparison were made by adding variables to each previous model to compare the
proportion of explained variance in substance use relapse rates. The previously listed analyses
were utilized for the following hypotheses:
Hypothesis 1: The relationship between self-compassion (SCS-SF) and substance use
relapse risk (AWARE) will be significantly negatively correlated. Participants who score
lower on self-compassion will have higher substance use relapse risk. A Pearson ProductMoment correlation will be conducted to assess the relationship between SCS-SF scores
and AWARE scores.
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Hypothesis 2: The relationship between self-efficacy (DASES) and substance use relapse
risk (AWARE) will be significantly negatively correlated. Participants who score lower
on self-efficacy will have higher substance use relapse risk. A Pearson Product-Moment
correlation analysis will be conducted to assess the relationship between DASES scores
and AWARE scores.
Hypothesis 3: The relationship between mindfulness (FFMQ-SF) and substance use
relapse risk (AWARE) will be significantly negatively correlated. Participants who score
lower on mindfulness will have higher substance use relapse risk. A Pearson ProductMoment correlation analysis will be conducted to assess the relationship between FFMQSF scores and AWARE scores.
Hypothesis 4: Participants who score lower on self-compassion, self-efficacy, and
mindfulness will have higher substance use relapse risk. A hierarchical multiple
regression analysis will be conducted to assess the relationship between SCS-SF scores,
DASES scores, FFMQ-SF scores, and AWARE scores. Variables will be entered based
on previous literature on connected relationships between self-efficacy, mindfulness, and
self-compassion in predicting substance use relapse risk. In line with previous research,
the first model will include participant total scores on the DASES predicting participant
total scores on the AWARE. Also, in line with previous research, a second model will
include participant total scores on the DASES and the FFMQ-SF in explaining the
variance in participant total scores on the AWARE. Finally, a third model will be created
that will include participant total scores on the DASES, the FFMQ-SF, and the SCS-SF in
explaining the variance in participant total scores on the AWARE. The covariate of
amount of time in treatment will be included in the regression model. It is hypothesized
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that the difference in the proportion of explained variance between the second and third
model will be statistically significant and the added variable of participant total scores on
the SCS-SF will explain the variance in participant total scores on the AWARE beyond
the variables in the second model.

CHAPTER 3: RESULTS
Descriptive Statistics
Data were collected from 87 participants. Ten participants failed to complete each
questionnaire within the questionnaire packet; therefore 77 participants were included in the final
analysis. A post-hoc power analysis was conducted where the total sample size of 77
participants, and three total predictors, for a medium effect size was entered into G*Power (Faul,
Erdfelder, Buchner, & Lang, 2009) and a power of 0.8 was maintained. Participants were
recruited from group-based WVU Medicine treatment programs including outpatient substance
use treatment services at Chestnut Ridge Center, Lakewood Center, the residential treatment
program Center for Hope and Healing, and the intensive outpatient program.
The average age of the sample was 35.2 years, ranging from 19 to 62. The average
number of times participants reported being in substance use treatment was 4.6 times, ranging
from one to 18. The average number of times participants reported relapsing in the past six
months was 8.1 times, ranging from 0 to 180. The average number of days reported in their
current substance use treatment recovery was 398.6 days, ranging from two to 3,650 days. In
terms of household income, the average amount was 22,633.53 dollars ranging from zero to
130,000 dollars. Forty-four (50.6%) participants self-identified as male, 42 (48.3%) selfidentified as female, and one (1.1%) self-identified as transgender male to female. The ethnic
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diversity of participants included six (7.04%) participants identifying as African-American, one
(1.2%) participant identifying as Hispanic or Latino/a, 77 (89.5%) participants identifying as
Caucasian American or White, and two (2.3%) participants identifying as Biracial or
Multicultural American. Seven (8.0%) participants identified their primary drug of choice as
alcohol, six (6.9%) participants as crack, 29 (33.3%) participants as heroin, 18 (20.7%)
participants as methamphetamine, four (4.6%) participants as cocaine, three (3.4%) participants
as amphetamines or “uppers”, four (4.6%) participants as benzodiazepines or “downers”, four
(4.6%) participants as marijuana, and 12 (13.8%) participants as other or “prescription pain
killers”. Finally, participants were asked about their frequency of attendance in their substance
use treatment groups. One (1.3%) participant reported attending substance use groups zero times
in a week, 27 (34.6%) participants reported attending daily, 30 (38.5%) participants reported
attending weekly, 15 (19.2%) participants reported attending bi-weekly, five (6.4%) participants
reported attending multiple days per week. Tables three and four provide a visual representations
of participant demographics.

Table 3
Demographic Characteristics of Participants
Characteristic
Gender
Male
Female
Transgender M2F
Ethnic/Racial Identity
African American or Black
Hispanic or Latino/a

Full sample
n

%

44
42
1

50.6
48.3
1.1

6
1

7
1.2
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Caucasian American or White
Biracial or Multicultural American
Primary Drug of Choice
Alcohol
Crack
Heroin
Methamphetamine
Cocaine
Amphetamines “Uppers”
Benzodiazepines “Downers”
Marijuana
Other
Frequency of Group Participation
None
Daily
Weekly
Bi-Weekly
Multiple Days Per Week

77
2

89.5
2.3

7
6
29
18
4
3
4
4
12

8
6.9
33.3
20.7
4.6
3.4
4.6
4.6
13.8

1
27
30
15
5

1.3
34.6
38.5
19.2
6.4

Note. N = 87. Participants were on average 35.2 years old (SD = 8.6).
Table 4
Means and Standard Deviations for Demographic Characteristics
Characteristic
Age
Times in Treatment
Number of Relapses in
Past 6 Months
Current Treatment
Duration (Days)
Household Income

M
35.2
4.6
8.1

Mdn
34
3
2

Mode
29
1
0

SD
8.6
3.9
23.2

Range
19-62
1-18
0-180

398.6

60

60

771

2-3650

22633.5

12000

0

28337.9

0-130000

Primary Analyses
H1: The relationship between self-compassion (Self-Compassion Scale-Short Form; SCS-SF)
and substance use relapse risk (Advanced Warning of Relapse Measure; AWARE) will be
significantly negatively correlated in a sample of individuals recovering from addiction.
Participants who score lower levels of self-compassion will be predicted to have higher
substance use relapse risk.
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Correlation coefficients are presented in Table One. For the first hypothesis, a Pearson's
product-moment correlation was conducted to assess the relationship between relapse risk and
self-compassion in individuals recovering from addiction. Preliminary analyses showed the
relationship to be linear with both variables normally distributed, as assessed by Shapiro-Wilk's
test (p > .05), and there were no outliers. There was a statistically significant, moderate negative
correlation between relapse risk and self-compassion, r(79) = -.47, p < .001, with selfcompassion explaining 22.1% of the variation in relapse risk. Therefore, we can reject the null
hypothesis and accept the alternative hypothesis.
H2: The relationship between self-efficacy (Drug Avoidance Self Efficacy Scale; DASES) and
substance use relapse risk (AWARE) will be significantly negatively correlated in a sample of
individuals recovering from addiction. Participants who score lower levels of self-efficacy will
be predicted to have higher substance use relapse risk.
For the second hypothesis, a Pearson's product-moment correlation was run to assess the
relationship between relapse risk and self-efficacy in individuals recovering from addiction.
Preliminary analyses showed the relationship to be non-linear with relapse risk being normally
distributed, but self-efficacy scores deviated from a normal distribution as assessed by ShapiroWilk's test (p = .04). There was a statistically significant, large negative correlation between
relapse risk and self-efficacy, r(78) = -.64, p < .001, with self-efficacy explaining 41% of the
variation in relapse risk. Since, this relationship was found to be non-linear, an additional
Spearman's rank-order correlation for this non-parametric data was run to assess the relationship
between relapse risk and self-efficacy in individuals recovering from addiction. There was a
strong, negative correlation between relapse risk and self-efficacy, which was statistically
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significant (rs(78) = -.63, p < .001). Therefore, we can reject the null hypothesis and accept the
alternative hypothesis.
H3: The relationship between mindfulness (Five Facet Mindfulness Questionnaire – Short Form;
FFMQ-SF) and substance use relapse risk (AWARE) will be significantly negatively correlated
in a sample of individuals recovering from addiction. Participants who score lower levels of
mindfulness will be predicted to have higher substance use relapse risk.
For the third hypothesis, a Pearson's product-moment correlation was conducted to assess
the relationship between relapse risk and trait mindfulness in individuals recovering from
addiction. Preliminary analyses showed the relationship to be linear with both variables normally
distributed, as assessed by Shapiro-Wilk's test (p > .05), and there were no outliers. There was a
statistically significant, large negative correlation between relapse risk and trait mindfulness,
r(78) = -.65, p < .001, with trait mindfulness explaining 42% of the variation in relapse risk.
Therefore, we can reject the null hypothesis and accept the alternative hypothesis.
H4: In addition to the variance explained in relapse risk (AWARE) by self-efficacy (DASES),
and mindfulness (FFMQ-SF), there will be a positive impact and an incremental explanation of
variance by self-compassion (SCS-SF) in a sample of individuals recovering from addiction.
Participants who score lower levels of self-compassion, self-efficacy, and mindfulness will be
predicted to have higher substance use relapse risk.
For the fourth hypothesis, a hierarchical multiple regression was conducted to determine
if the addition of trait mindfulness and then of self-compassion improved the prediction of
relapse risk over and above self-efficacy alone. See Table Two for full details on each regression
model. There was evidence of linearity as assessed by partial regression plots and a plot of
studentized residuals against the predicted values. There was evidence of independence of
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residuals, as assessed by a Durbin-Watson statistic of 1.629. This indicates that the observations
in the data were not related or auto-correlated. Finally, there was evidence of homoscedasticity,
as assessed by visual inspection of a plot of studentized residuals versus unstandardized
predicted values. The presence of homoscedasticity indicates that all variables have the same
finite variance. There was no evidence of multicollinearity, as assessed by tolerance values
greater than 0.1. The independent variables of self-efficacy, trait mindfulness, and selfcompassion were not highly correlated with each other which prevented misunderstanding of
which predictor variable contributed to the variance explained in relapse risk. There were no
studentized deleted residuals greater than ±3 standard deviations, no leverage values greater than
0.2, and values for Cook's distance above one. This indicates there were no significant outliers,
high leverage points, or high influential points. There assumption of normality was met, as
assessed by Q-Q Plot, which indicates that the number of minor influences or errors followed a
normal distribution and the F- test was applicable. The full model of self-efficacy, trait
mindfulness, and self-compassion to predict relapse risk (Model 3) was statistically
significant, R2 = .544, F(3, 73) = 28.977, p < .001; adjusted R2 = .525. The regression equation
was: predicted relapse risk = 212.747 + (-0.509 x DASEStotal) + (-0.855 x FFMQSFtotal) + (0.132 x SCSSFtotal). With self-efficacy, the addition of trait mindfulness to the prediction of
relapse risk (Model 2) led to a statistically significant increase in R2 of .127, F(2, 74) =
43.865, p < .001; adjusted R2 = .530. The regression equation was: predicted relapse risk =
212.571 + (-0.519 x DASEStotal) + (-0.899 x FFMQSF). Self-efficacy predicting relapse risk
(Model 1) was statistically significant, F(1, 75) = 53.379, p < .001; adjusted R2 = .408. The
addition of self-compassion to the prediction of relapse risk (Model 3) did not lead to a
statistically significant increase with a R2 value of .001, F(3, 73) = 28.977, p = .675. The
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regression equation was: predicted relapse risk = 174.502 + (-0.867 x DASEStotal). These initial
results called for an additional analysis to test of a mediation effect.

Table 2
Hierarchical Regression Results for Relapse Risk
Variable

B

95% CI for B
LL
UL

SE B

β

Step 1
Constant
174.50*** 152.87 196.13 10.86
Self-efficacy
-.87***
-1.10
-.63
0.12
-.65***
Step 2
Constant
212.57*** 187.03 238.11 12.82
Self-efficacy
-.52***
-.78
-.26
0.13
-.39***
Trait mindfulness
-.90***
-1.29
-.50
0.20
-.44***
Step 3
Constant
212.75*** 187.04 238.45 12.90
Self-efficacy
-.51***
-.78
-.24
0.13
-.38***
Trait mindfulness
-.86***
-1.30
-.41
0.23
-.42***
Self-compassion
-.13
-.76
.49
0.31
-.04
Note. CI = confidence interval; LL = lower limit; UL = upper limit.
*p < .05. **p < .01. ***p < .001.

R2

ΔR2

.42

.42***

.54

.13***

.54

.00
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Test of Mediation. Initial evidence for a mediating effect is observed in Table 5. In this step, the
effect of self-compassion, which is significant in the other models, is no longer present when
trait mindfulness is added to the model (i.e: β = -.06; SE= .33; p=.59). This type of finding can
suggest mediation is occurring (Baron & Kenny, 1986). To test this possible mediation further,
Table 6 displays the results of the Baron and Kenny (1986) four step method which was
conducted. The first three steps of this method establish the zero-order relationships among the
mediation model variables. In the fourth step mediation is demonstrated when, with the
inclusion of the mediator variable into the regression model, the initial relationship between the
main predictor variable and outcome variable is no longer significant (Baron & Kenny, 1986).
As seen in Table 6, when self-compassion and trait mindfulness were entered in the fourth
model, the relation of trait mindfulness to relapse risk remained significant (β = -.56; SE= .22;
p<.001) and the relation of self-compassion to relapse risk was no longer significant (β = -.14;
SE= .34; p=.204). These findings suggest that trait mindfulness fully mediates the relationship
between self-compassion and relapse risk.
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Figure 1
Mediation Model with Self-Compassion, Trait Mindfulness, and Relapse Risk
Mediator:
β = .580

Trait Mindfulness

p < .001

p < .001

Predictor Variable:
Self-Compassion

β = -.647

Outcome:
β = -.471

Relapse Risk

p < .001
β = -.139
p =.122

Figure 1. Model testing mediation of the relationship between self-compassion and relapse risk
by trait mindfulness. Values in parentheses represent the standardized relation of selfcompassion to relapse risk after controlling for trait mindfulness.
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Exploratory Analyses
Group Differences. A one-way ANOVA was conducted to determine if self-efficacy
(DASES), trait mindfulness (FFMQ-SF), self-compassion (SCS-SF), and relapse risk (AWARE)
was different for groups with different primary substances of choice. Participants were classified
into eight groups: alcohol (n = 7), crack (n = 6), heroine (n = 29), methamphetamine (n = 17),
cocaine (n = 4), amphetamines “uppers” (n = 3), benzodiazepines “downers” (n = 4), marijuana
(n = 4), and other (prescription opioids) (n = 12). The differences between these groups with
different primary substances of choice were not statistically significant across self-efficacy, F(8,
77) = 1.991, p = .059, trait mindfulness, F(8, 76) = 1.590, p = .142, self-compassion, F(8, 77) =
0.978, p = .460, or relapse risk, F(8, 70) = 1.504, p = .172.

CHAPTER 4: DISCUSSION
Summary of Findings
The current study explored the relationships among self-efficacy, trait mindfulness, selfcompassion, and relapse risk in a sample of individuals enrolled in substance use recovery
programs. Three of the four hypotheses indicated statistically significant results. Specifically, the
findings indicated associations between relapse risk and self-compassion, relapse risk and selfefficacy, and relapse risk and trait mindfulness. The amount of variance explained in relapse risk
by self-efficacy and mindfulness was not found to be statistically significant apart from the
variance explained by self-compassion, thus not supporting the fourth hypothesis. However, after
additional analyses, trait mindfulness was found to fully mediate the relationship between selfcompassion and relapse risk. This chapter will discuss the results of each analysis, possible
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explanations for the findings, strengths and limitations of the study, clinical implications, and
future directions for research in this area.
Explanation for Findings
Hypothesis 1. Participant responses indicated a significant negative relationship between
relapse risk and self-compassion, suggesting that greater levels of self-compassion are associated
with lower levels of relapse risk in individuals recovering from substance use. Self-compassion
is defined as a balance of cognitive and affective processes where individuals express kindness
and understanding to themselves (Neff 2003b; 2016). Key components that have been associated
with relapse in substance use recovery are feelings of failure, guilt, self-hatred, and self-blame
(Uslaner et al., 1999) as well as negative affective states (Brown et al., 1989). If an individual
recovering from substance use understands their condition and process while also evaluating
their experiences nonjudgmentally and perceiving their experiences as shared with humanity, it
makes sense that these self-compassionate individuals would be less likely to relapse. This
finding is consistent with the little research that has explored this relationship (Tanaka et al.,
2011; Vettese et al., 2011). Though the relationship between relapse risk and self-compassion
was significant in this study, this novel finding is consistent with research investigating the
relationship between substance use and self-compassion. This finding suggests that selfcompassion may be a useful intervention in therapy for those recovering from substance use
disorders and to aid in relapse prevention. Previous literature supporting this relationship also
suggests a negative correlational relationship between self-compassion and substance use
disorders (Brooks et al., 2012) and a negative probability of developing a substance use disorder
(Miron et al., 2014).
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The current result also adds support to previous findings regarding the relationship
between the risk of using illicit substances and self-compassion (Vettese et al., 2011; Weiss et
al., 2015). Although the association continues to be explored between self-compassion and
relapse risk, further and more recent research continues to find consistent findings with that of
the first hypothesis; specifically of an inverse relationship between substance use and selfcompassion (Phelps, Paniagua, Willcockson, & Potter, 2018).
Hypothesis 2. Participant responses indicated a significant negative relationship between
relapse risk and self-efficacy, suggesting that greater levels of self-efficacy are associated with
lower levels of relapse risk in individuals recovering from substance use. Since high self-efficacy
has been previously found in individuals with less stress, higher self-regulation behaviors, less
personalization of failures, and higher acts of striving for achievement (Bandura, 1982), it is
sensible as to why these individuals are less likely to relapse. The current study’s finding is
consistent with the self-efficacy literature that has supported its role in substance use relapse
(Ilgen et al., 2007; Ilgen et al., 2006; Moos & Moos, 2006; Trucco et al., 2007). This specific
result also is contrary to the previous findings of self-efficacy having limited relation to relapse
risk (Burling et al., 1989; Ilgen et al., 2005), which suggests that self-efficacy may be more of a
potent predictor of relapse than previously thought. The current finding is also indicative of the
length of abstinence from substance use. Much like Kelly and Greene’s (2014) findings, current
results suggest that self-efficacy can increase the length of abstinence in an individual’s sobriety
Only 8% of participants in the current study identified their drug of choice as alcohol, yet
findings indicated that self-efficacy was negatively correlated to relapse risk regardless. This is
contrary to previous literature, which indicated that self-efficacy was a factor for risk of relapse
only in those whose drug of choice was alcohol (El et al., 2004). Perhaps a methodological
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shortcoming of El et al.’s (2004) study was the use of a self-efficacy measure that was not
designed specifically for individuals recovering from substance use. The current study aimed to
avoid this same limitation and used a measure that was designed to assess for level of selfefficacy in drug avoidance.
Hypothesis 3. Participant responses indicated a statistically significant negative
relationship between trait mindfulness and relapse risk, such that greater levels of trait
mindfulness are associated with lower levels of relapse risk. Trait mindfulness was originally
defined as the propensity toward mindfulness in everyday life and consists of increased
awareness and attention in present reality or current activity (Brown & Ryan, 2003). Being
mindful consists of being aware of and focusing on current experience, which involves
concentrating on behavior that is typically out of conscious awareness and attention (Kabat-Zinn,
1990; Segal et al., 2002). Previous literature has found that mindfulness is positively associated
with several dimensions of wellbeing and negatively associated with components of
psychological and emotional disturbance as well as being predictive of self-regulation and
positive emotional states (Brown & Ryan, 2003). In order for individuals to successfully refrain
from relapse, they must be able to be consciously aware of their recovery, their triggers, and their
attitudes. This adds support to the previous findings of a negative association between trait
mindfulness and substance use (Bowen & Enkema, 2014; Fernandez et al., 2010; Robinson et al.,
2014) while going against positive associations between trait mindfulness and substance use
factors (Leigh et al., 2005; Leigh & Neighbors, 2009). The current findings also provide support
to the more specific relationship between trait mindfulness and relapse risk in substance use.
Given this definition and the relationships with trait mindfulness, the current finding of the
relationship between trait mindfulness and relapse risk is logical.
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Hypothesis 4. It was hypothesized that self-efficacy, trait mindfulness, and selfcompassion would predict relapse risk. Self-efficacy was found to be a significant predictor for
relapse risk, and after adding trait mindfulness into the model, there was significantly more
variance explained for relapse risk. After adding self-compassion into the model in combination
with self-efficacy and trait mindfulness, the model was found to be still predictive of relapse risk;
however, self-compassion did not add a significant amount of variance to the model. Given the
previous literature regarding the relationships between self-efficacy and substance use (Ilgen et
al., 2007; Ilgen et al., 2006; Moos & Moos, 2006; Trucco et al., 2007), and trait mindfulness and
substance use (Bowen & Enkema, 2014; Fernandez et al., 2010; Robinson et al., 2014), it is
understandable as to why these factors are further supported as potent predictors of substance use
relapse risk. Although the current findings indicate self-compassion is negatively associated with
relapse risk, the findings also suggest that self-compassion is not significantly different from
self-efficacy and trait mindfulness in the prediction of relapse risk. The current finding also adds
mixed results to Vettese et al.’s (2011) finding of self-compassion being predictive of addiction
severity. However, when combined with self-efficacy and trait mindfulness, self-compassion
may still be a valued component in substance use treatment in the prevention of relapse.
Additional analyses revealed that trait mindfulness fully mediated the significant
relationship between self-compassion and relapse risk. This relationship suggests those in
recovery from substance use need to possess a level of mindfulness (trait mindfulness) to
develop a compassionate view of themselves (self-compassion) and thus, lead to a lesser risk of
relapsing into substance use (risk of relapse). Ultimately, these findings shed light on the process
in which mindfulness is an essential element of self-compassion while also informing the process
in which an individual’s level of self-compassion can be predictive of their risk of relapse into
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substance use. Results from the current study are consistent with previous literature (Garner,
Gilbert, Shorey, Gordon, Moore & Stuart, 2020; Phelps, Paniagua, Willcockson, & Potter, 2018)
and thus, support the notion that an individual’s self-compassion is a powerful predictor of risk
of relapse.
Exploratory Analyses. Further exploratory analyses were done to determine if selfefficacy (DASES), trait mindfulness (FFMQ-SF), self-compassion (SCS-SF), and relapse risk
(AWARE) were different for groups with different primary substances of choice. Additional
exploratory analyses were conducted to observe if a mediation effect was occurring by trait
mindfulness mediating the relationship between self-compassion and relapse risk. No significant
group differences were found between groups with differing primary substances of choice.
Although no significant group differences were found within the current sample, future research
is needed to determine if group differences exist amongst these variables and conducted with
equal group sizes and a sufficient number of participants in each group.
Implications of Findings
Self-Efficacy in Substance Use Treatment. There are several implications that can be
derived from the current study’s results. First, self-efficacy was found to be negatively correlated
with and predictive of relapse risk in individuals recovering from substance use. Previous
research has found that self-efficacy was higher among abstainers than individuals who had
relapsed, but it was not predictive of a positive treatment outcome (Burling et al., 1989). Other
research has found self-efficacy evaluations to be predictive of successful abstinence
(DiClemente, 1986) while Ilgen et al. (2005) found that self-efficacy was not always predictive
of abstinence after a one-year follow-up. The implications of the current findings are consistent
with the results reported by Burling et al. (1989) but leave the question of self-efficacy’s ability
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to predict absence of relapse after a certain time unanswered. Future research is needed to add
clarity to the question of self-efficacy being predictive of long-term recovery. It is also evident
from the current findings that self-efficacy is not the only individual factor that is predictive of
substance use relapse. Other factors such as trait mindfulness were found to add value in
predicting relapse risk, which implies that self-efficacy is insufficient in its sole predictive value.
In terms of substance use treatment, the current results imply that interventions designed
to enhance self-efficacy must be present to some degree. Self-efficacy was predictive of relapse
risk specifically in individuals recovering from substance use and seems to validate Witkiewitz
and Marlatt’s (2004) call for relapse prevention models to include self-efficacy. Bandura
(1986) identified four principal sources of efficacy beliefs: performance attainments; vicarious
experiences of observing the performance of others; verbal persuasion to try to convince people
that they possess certain capabilities; and physiological states based on which people judge their
capabilities, strengths, and vulnerabilities. If individuals recovering from substance use are
taught coping skills (e.g., problem-solving, social skills, communication skills) and they directly
experience success afterword because of implementing those skills, this perceived success is
likely to enhance their efficacy beliefs and thus reduce the likelihood of relapse. The aspect of
assigning homework practice exercises has been found to be supported in the enhancement of
self-efficacy. Annis, Schober, and Kelly (1996) found that homework tailored to individuals’
high-risk situations is beneficial for increasing self-efficacy. They identified six aspects of
homework assignments that are expected to alter perceived efficacy, along the lines suggested by
Bandura (1986): (1) the homework assignments must be challenging, (2) they should require a
moderate degree of effort, (3) they should require little external aid, (4) success in the
assignments should be perceived as part of a pattern of improved performance, (5) the

ROLES IN RELAPSE RISK

64

assignments should increase the perception of personal control and decrease reliance on external
supports, and (6) the assignments should be relevant to problem situations frequently
encountered (Annis et al., 1996).
Curry and Marlatt (1987) also emphasized the importance of tailoring interventions
aimed at enhancing self-efficacy and recommended keeping homework assignments simple, to
maximize the likelihood of success and increase self-efficacy. Another method of enhancing the
self-efficacy of substance abusing clients includes Motivational Interviewing (MI). Miller and
Rollnick (2002) stated that “supporting self-efficacy” is one of the guiding principles of
motivational interviewing. MI includes strategies that facilitate the development of self-efficacy,
such as expressing confidence in the client’s ability to change, reviewing past successes and
current strengths, using the confidence ruler technique, presenting a number of change options,
and developing explicit strategies for implementing changes (Miller & Rollnick, 2002). The
present research indicates that self-efficacy is an element that needs to be included in substance
use treatment to have an effect on relapse risk. Previous research indicates that this factor can
also be an element of change for individuals with substance use disorders vulnerable to relapse
(Annis et al., 1996; Curry & Marlatt, 1987; Miller & Rollnick, 2002). Further research should
include longitudinal results after implementing self-efficacy-enhancing methods in efforts to
reduce the likelihood of relapse.
Mindfulness in Substance Use Treatment. The current findings also included the
negative association between trait mindfulness and relapse risk. This implies that an individual
recovering from substance use has an additional factor that plays a role in their relapse
prevention. Although the causality of the relationship cannot be derived from the current results,
a significant association exists between the two factors. In addition, trait mindfulness was found
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to explain a significant amount of variance in predicting relapse risk. This finding implies that
mindfulness may play a more significant role in substance use treatment than previously thought.
Previous research has found mindfulness to be deficient for individuals seeking substance use
treatment (Shorey et al., 2013) and has been linked to specific factors of relapse such as craving
(Garland et al., 2014), maladaptive schemas (Shorey, Anderson et al., 2015; Shorey, Brasfield, et
al., 2015), and problematic use (Karyadi & Cyders, 2015). The current finding of the negative
association between trait mindfulness and relapse risk adds further clarity to the mixed results
between these two factors (Leigh et al., 2005; Leigh & Neighbors, 2009) and begins to answer a
call for further research (Appel & Kim-Appel, 2009).
A clinical implication of the current findings is further support of the utility of
mindfulness-based relapse prevention (MBRP). Previous research has found significant
decreases in overall days of substance use and craving post-MBRP treatment for individuals in
recovery (Bowen et al., 2009). Significant increases found in levels of awareness and acceptance
post-MBRP treatment were the positive effects for individuals recovering from substance use
(Bowen et al., 2009). This treatment has been found to be effective in preventing relapse in
populations with severe SUDs (Bowen et al., 2014; Roos et al, 2017; Zemestani & Ottaviani,
2016). Within MBRP, identification of high-risk situations remains central to the treatment.
Participants in MBRP are trained to recognize early warning signs for relapse, increase
awareness of internal (i.e., emotional and cognitive) and external (i.e., situational) cues
previously associated with substance use, develop effective coping skills, and enhance selfefficacy. Mindfulness practices included in MBRP are intended to raise awareness of triggers,
monitor internal reactions, and foster more skillful behavioral choices. The practices focus on
increasing acceptance and tolerance of positive and negative physical, emotional, and cognitive
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states such as craving, thereby decreasing the need to alleviate these negative affective states
through relapse. The current findings also imply that trait mindfulness may be an efficient gauge
for where individuals are in their recovery. For example, if an individual is found to have low
trait mindfulness, it is logical to predict that the same individual’s likelihood of relapse is high
during that time, given the current results. As stated previously, trait mindfulness also introduces
a separate intrinsic factor for change while in substance use treatment. If this component were
one of few to be made central in substance use treatment using practices already supported in this
population, such as MBRP, it is reasonable to conclude that the risk of relapse will be lower
compared to treatments as usual that lack a mindfulness component. Future research should
explore the longitudinal effects of MBRP in combination with self-efficacy practices;
specifically, on the rate of relapse for individuals recovering from substance use.
Self-Compassion in Substance Use Treatment. The final significant finding of this
study was the negative association between self-compassion and relapse risk. However, causality
cannot be derived from the current results. We cannot determine if those who are at high risk of
relapse begin to lose self-compassion, or if low self-compassion increases the risk of relapse.
Previous research lends support to the notion of self-compassion being addressed while in
substance use treatment, indicating that self-compassion may need to be included as a part of
treatment for this population. Previous studies have found those in recovery from substance use
disorders exhibit hatred and negative attitudes toward themselves, leading to more frequent
relapse behaviors (Brown et al., 1989; Ulsaner et al., 1999). Neff’s (2003; 2004) concept of selfcompassion encourages the development of healthier self-attitudes that are meant to treat
negative attitudes toward the self and promote more self-kindness and less critical self-judgment.
Self-compassion has also been found to be positively associated with positive coping strategies
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and negatively associated with maladaptive coping strategies (Neff et al., 2004). In terms of
substance use, previous research has found that self-compassion is predictive of addiction
severity (Vettese et al., 2011), and until the current research, was not studied in its relationship to
relapse risk. Although the current study was unable to derive a predictive relationship between
the two variables, the correlational results imply that self-compassion-oriented treatments may
have a place in substance use treatment.
Gilbert and Procter (2006) developed a self-compassion-oriented therapy called
Compassionate Mind Training (CMT). This therapy was developed for individuals with high
shame and self-criticism, and for those who find self-warmth and self-acceptance difficult.
Compassionate Mind Training has been found to significantly reduce levels of depression,
anxiety, self-criticism, shame, inferiority, and submissive behavior (Gilbert & Procter, 2006).
CMT has also been found to improve participants’ abilities to be self-soothing and provide selfreassurance (Gilbert & Procter, 2006).
An additional self-compassion-oriented treatment is Compassion Focused Therapy (CFT)
(Gilbert, 2009). While CMT refers to specific activities designed to develop compassionate
attributes and skills, particularly those that influence affect regulation, CFT refers to the
underpinning theory and process of applying a compassion model to psychotherapy (Gilbert,
2009). The aim of CFT is to replace feelings of hostility and insecurity toward oneself with
compassion and understanding, so that individuals can learn to soothe themselves, accept
soothing from others, and generate feelings of contentment and safety. CFT is just beginning to
be researched in terms of feasibility for those recovering from substance use, and results indicate
that those with substance use disorders desire more CFT sessions and that it is feasible and welltolerated (Carlyle et al., 2019). However, CFT has only been implemented in populations with
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opioid use disorder, and future research should consider implementing this therapy with
individuals recovering from any substance use disorder. Additionally, CFT has not been
measured in terms of its effect on prolonged substance use relapse. Future research needs to
determine the longitudinal effects of CFT on preventing relapse in those recovering from
substance use. The current study collected data from individuals diagnosed with substance use
disorders ranging across all types. Given that the current results were found within a population
varying in substance use disorders, it is reasonable to believe CFT may benefit those in recovery
from all or most substances.
A separate self-compassion-oriented treatment that has begun to be researched in treating
those with substance use disorders is brief self-compassion training (BSCT). BSCT, developed
by Held, Owens, Thomas, White, and Anderson (2018), was derived from practices used in other
compassion-based interventions, such as mindful self-compassion (Neff & Germer, 2013) and
compassion-focused therapy (Gilbert & Procter, 2006). Generally, BSCT relies on several
cognitive-behavioral strategies to help participants change their perspectives. BSCT is a
structured, four-session intervention that was designed to teach participants core self-compassion
skills (Held et al., 2018). BSCT is delivered in a group format over the course of four weekly 60minute sessions. Participants learn and practice new self-compassion skills each week and are
encouraged to complete homework assignments to further facilitate skills practice between
sessions (Held et al., 2018). Pilot results of this program with individuals in substance use
treatment programs include significant increases in self-compassion, emotional intelligence, and
presence of meaning in life, and statistically significant decreases in trauma-related guilt and
shame (Held et al., 2018). Much like research regarding CFT, little to no research has examined
the effect of BSCT on relapse in substance use populations. Future research should assess the
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effect of this therapy on individuals recovering from substance use and their risk of relapse. The
current findings imply that a relationship exists between self-compassion and relapse risk in
individuals recovering from substance use; however, this is a novel discovery in the association
of these two factors. Further research is needed to clarify this relationship and to derive effects of
self-compassion-oriented therapies on the risk of relapse.
Integrating the Three Treatments
It is evident from the previous implications that each of the three tested variables plays a
role in substance use relapse and can be utilized in various treatments. However, greater success
in preventing substance use relapse could possibly be had when integrating the three treatment
models (i.e., self-efficacy relapse prevention, MBRP, CFT). Integrated treatment models have
been previously found to be superior to treatment of individual disorders with separate treatment
plans (Kelly & Daley, 2013). Elements that could be taken from self-efficacy-oriented treatment
models include the teaching of coping skills (e.g., problem-solving, social skills, communication
skills) and homework designed to increase self-efficacy (Annis et al., 1996). Additionally, the
component of motivational interviewing would address the development of self-efficacy and
explicit strategies for implementing changes (Miller & Rollnick, 2002). Possible areas essential
for the recovery from substance use and in the prevention of relapse would be addressed by these
self-efficacy-enhancing treatment elements.
The elements found to reduce the likelihood of relapse from mindfulness-based
interventions have been previously integrated with positive results (Bowen et al., 2009; Roos et
al, 2017; Zemestani & Ottaviani, 2016). An integrated treatment would focus on previouslyunaddressed areas of relapse such as craving (Garland et al., 2014), maladaptive schemas
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(Shorey, Anderson et al., 2015; Shorey, Brasfield, et al., 2015), problematic use (Karyadi &
Cyders, 2015) and prolong overall days of abstinence and decrease craving (Bowen et al., 2009).
An example of an integrated model with elements of self-efficacy and mindfulness is
MBRP; this model promotes identification of high-risk situations, recognition of early warning
signs for relapse, increasing awareness of internal (i.e., emotional and cognitive) and external
(i.e., situational) cues previously associated with substance use, developing effective coping
skills, and enhancing self-efficacy. As previously mentioned, mindfulness may be an efficient
gauge for where individuals are in their recovery, thereby providing an estimate for likelihood of
relapse. This would introduce a new component to the self-efficacy-enhancing interventions.
Despite these areas of substance use relapse addressed, there remains an unaddressed area
of self-attitudes as indicated by the current results. Previous self-compassion treatment models
have been found to significantly reduce levels of depression, anxiety, self-criticism, shame,
inferiority, and submissive behavior (Gilbert & Procter, 2006) and facilitate the ability of
individuals to soothe themselves, accept soothing from others, and generate feelings of
contentment and safety (Gilbert, 2009). More recently, the self-compassion-oriented treatment
model of BSCT with individuals in substance use treatment programs have resulted in significant
increases in self-compassion, emotional intelligence, presence of meaning in life, and statistically
significant decreases in trauma-related guilt and shame (Held et al., 2018). Based on the current
findings and previous research concerning the effectiveness of these treatments for substance
use, it is logical to conceive of an integrated treatment model that combines these elements to
address the variability in relapse for those in recovery. Future research needs to examine the
feasibility of combining these treatment orientations and address the effectiveness and the
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applicability to the substance use population. If positive results are found from this proposed
integrated treatment, several measurements are needed to validate its use in relapse prevention.
Strengths of the Study
There are several strengths of the design of the current study. One strength pertains to the
aim of the study; specifically, to fill gaps in the literature concerning self-efficacy (El et al.,
2004), mindfulness (Bowen & Enkema, 2014; Karyadi et al., 2014; Shorey et al., 2013), selfcompassion (Iskender, 2009; Vettese et al., 2011), and relapse risk (Ilgen et al., 2005; 2006) in
the substance use population. The examination of associations between these four variables
addresses gaps in the literature as well as provides further strength to previously-researched
relationships with substance use and the less examined substance use variable of relapse risk.
A second strength of this study is the use of the AWARE (Miller & Harris, 2000) as a
measure of relapse risk. To date, very few studies have used this measure in relation to selfefficacy, mindfulness (Crescentini, Matiz, & Fabbro, 2015), and self-compassion. This is
important because the AWARE is one of the few well-validated measures of relapse risk without
needing participants to engage in the process of relapse. Additionally, the AWARE measure was
further validated in its use within the population of individuals recovering from substance use.
Further, the present study also replicated results found in previous studies using the variables of
mindfulness, self-efficacy, and self-compassion while also having found associations among
these variables and the AWARE measure of relapse risk which is a novel association using this
specific measure.
The method of data collection in the present study presents various strengths that are
important to note. First, the current study collected data from the most relevant population for
this research. Few studies outside of grant-funded research can access the substance use
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population. Most of the literature that examines these areas are assessed in college student
populations or with small samples from the substance use population. In the current study, I
worked diligently to ensure the data were collected from a population that was most expected to
benefit from its results. In an effort to broaden results, data were collected from various sources
including inpatient and outpatient clinical settings. To date, the present research is one of few
studies that examine the relationships among these variables in a sample of individuals
recovering from substance use disorders.
A separate strength of the data was its demographic breakdown and the resemblance it
shows with the state demographics of West Virginia. The present study sampled individuals who
were enrolled in either an inpatient or outpatient substance use treatment setting. The
demographics in the present study reflected the following racial breakdown: 89.5% Caucasian
American or White, 7.0% African American or Black, 1.2% Hispanic or Latino/a, 5.7%, and
2.3% biracial or multicultural American. Unfortunately, the racial demographic data of
individuals enrolled in substance use treatment is not known in the state of West Virginia.
However, the most recent U.S. Census Data for West Virginia as of 2018 indicated the following
racial breakdown of West Virginia citizens: 93.2% White, 3.7% Black or African American,
1.5% Hispanic, and 1.8% two or more races.
Limitations and Future Directions
Research design. Within the current study, there are various limitations that need to be
addressed. Specifically, the chosen research design presents threats to both internal and external
validity.
Threats to Internal Validity. The first three hypotheses are of a correlational research
design which creates difficulty in determining causality between factors. Being that no variables
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were manipulated in this study, the direction of the association in the first three hypotheses were
unclear. The purpose of using a correlational design for the first three hypotheses in this study
was to clarify the respective relationships between self-efficacy and relapse risk, and trait
mindfulness and relapse risk, as well as fill in the gap in the literature to determine whether a
relationship exists between self-compassion and relapse risk. Future research needs to better
determine causality using more complex research designs. Since the surveys in the current study
were all self-report measures, this methodology also poses a separate limitation. Heppner,
Wamphold, and Kivlighan (2008) explained that self-report methodology shares a common
respondent bias, and it also does not allow for extensive validation or reliability of the results.
Future directions of research should examine similar data from various sources including the
individual recovering from substance use, their substance use counselor or therapist, and close
family members. Measurement of these variables from various sources could add more reliability
to the relationships and introduce the possibility for more complex analyses to be conducted.
A separate limitation to the current study is the accurate measurement of intended
constructs. The measures chosen for this study included the AWARE, the DASES, the FFMQSF, and the SCS-SF. It is possible that different measures along with elongated forms of
measures may have been better suited to assess for the hypothesized relationships. Specifically,
the FFMQ conceptualized mindfulness as a multifaceted construct to help understand its
components with other variables (Baer, Smith, Hopkins, Krietemeyer, & Toney, 2006). The
current study utilized a total score of the FFMQ rather than compare the various facets of
mindfulness and their relationships with relapse risk. Future research should consider using the
multiple facets offered on the FFMQ or the FFMQ-SF to fully understand the specific
associations mindfulness has with relapse risk.
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An additional issue in accuracy of measurement was the use of the SCS-SF. In the current
study, the SCS-SF was used for testing convenience and prevent participants from becoming test
fatigued. However, the current results revealed that participant responses on the SCS-SF did not
account for significantly more variance in relapse risk than did participant responses on the
DASES and the FFMQ-SF. Perhaps, using the full form of the SCS (Neff, 2003) would have
added more data to the current hypotheses. Raes et al. (2011) noted that the short form of the
SCS has less reliability in terms of the subscale scores and recommended using the full form of
the SCS if interested in these scores. In future research, the subscale scores of the SCS should be
investigated in their association with relapse risk in efforts to possibly narrow down treatment to
a specific component of self-compassion.
The use of the DASES in the current study also is a concern for accuracy in
measurement. The intended use of the DASES was meant to measure the level of self-efficacy an
individual will report while recovering from substance use. However, Martin et al. (1995) stated
that the DASES was designed to measure self-efficacy concerning avoidance of substance use by
multiple-drug users. Although the current study included participants with poly-substance use,
the use of a more specific measure related to relapse may be necessary. A more appropriate
measure that could be utilized in future research is the Alcohol and Drug Use Self-Efficacy Scale
(ADUSE; Brown, Seraganian, Tremblay, & Annis, 2002). The ADUSE was designed to
specifically measure self-efficacy with respect to temptations to use and self-confidence in the
face of high-risk situations (Brown et al., 2002). Future research should consider the use of this
measure when assessing for self-efficacy in individuals abstaining from drug and alcohol use.
The final limitation related to the current study’s research design is that of employing a
cross-sectional design. The current study employed a one-time measurement of each of the
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variables within a population of individuals recovering from substance use. Since one of the
variables was that of relapse, the use of a longitudinal design would offer more specific points of
measurement across time. Limitations of a cross-sectional design include the inability to analyze
behavior over time, being unable to determine cause and effect, and lack of representation of the
population. Additionally, the original use of the AWARE measure was implemented in a
longitudinal design. Miller and Harris (2000) measured relapse risk during follow-up intervals of
time including four months, six months, eight months, 10 months, and 12 months. In future
research, assessing relapse risk would be better suited in a longitudinal design at marked time
lapses throughout substance use treatment.
Data analysis and findings. The first limitation in data analysis includes the removal of
participants’ incomplete data. A total of 10 survey responses were not included in the analyses
due to incomplete data. Upon visual inspection of the dataset, these participants’ data did not
reveal a systematic pattern of incompletion. It is suspected that these 10 participants’ data were
incomplete due to test fatigue. However, the measures were counterbalanced in the current study;
therefore, the cause of incompletion cannot be confirmed.
Future research should explore more complex data analyses to further investigate the
associations between the factors of self-compassion, mindfulness, self-efficacy and relapse risk.
One possible analysis that could be explored in future research is moderated regression.. A
moderated regression would assist in determining whether self-compassion influences the
strength or direction of the relationship between trait mindfulness, self-efficacy, and relapse risk.
To determine the order of the relationship between these variables, the more complex statistical
analysis of structural equation modeling could be utilized in future research. The current findings
begin to embark on possible relationships among these variables and warrant future research
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with the goal of understanding these relationships and promoting clinical application to
individuals recovering from substance use.
In addition, the SCS-SF and FFMQ-SF include several subscales as part of the measure,
and investigation into how their respected components relate to the current findings could yield
enlightening results that would further fill gaps in the literature. For example, the SCS-SF
includes six subscales (self-kindness, self-judgment, common humanity, isolation, mindfulness,
and over-identified) and the FFMQ-SF included five subscales (observe, describe, acting with
awareness, nonjudging of inner experience, and nonreactivity to inner experience). The current
results indicate a relationship exists between self-efficacy, trait mindfulness, self-compassion,
and relapse risk, but the analyses did not specify relationships with subscale scores. Future
research with larger samples should explore the specific subscales of these constructs to
determine the strength and direction of any possible associations.
Threats to External Validity. Regarding the findings of the study, three limitations stand
out that should be considered for the future directions of the literature. First, the lack of different
groups of participants throughout data collection resulted in an additional lack of information
regarding causality. Without a control group, it is difficult to conclude that low self-compassion
is related to relapse risk in individuals recovering from substance use. Future research could
benefit from including groups of participants recovering from substance use assigned to
differently oriented therapies derived from the theories of self-efficacy, mindfulness, and selfcompassion as well as a control group in order to strengthen the validity of concluding the
relationship between the respected variables. Combining this experimental design with
regression models would produce directional relationships among these variables, which would
eventually benefit clinical practice.
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The second limitation to be considered from the current study includes the collection of
information from participants regarding their reported number of times of relapse in the past six
months as well as number of times participants reported being in substance use treatment. These
demographic characteristics were not considered for the primary analyses because of the specific
hypotheses examining the relationships among self-efficacy, trait mindfulness, self-compassion,
and relapse risk. This is a limitation in this study, due to self-reported variables presenting the
potential for self-servicing bias. Further research in this area should consider objective
measurements of the number of relapse occurrences and number of times in substance use
treatment for this populations. Validity would be strengthened if these objective measures were
utilized. Additionally, if future studies were to use these demographic variables, it would assist
in further validating the relationships among self-efficacy, trait mindfulness, self-compassion,
and relapse risk. Since research examining the relationship between self-compassion and relapse
is in its infancy, Phelps et al. (2018) stated future research could explore if self-compassion
would improve treatment outcomes for individuals in substance use treatment.
An additional component for future research to consider is that self-compassion can be
taught through the treatment model of compassionate mind-training (CMT) (Gilbert & Procter,
2006). Gilbert and Procter (2006) reported that CMT was “developed for people with high shame
and self-criticism, whose problems tend to be chronic, and who find self-warmth and selfacceptance difficult and/or frightening” (p. 353). For individuals recovering from substance use,
it has been previously found that obstacles in abstinence include feelings of failure, guilt, selfhatred, and self-blame (Uslaner et al., 1999) as well as negative affective states (Brown et al.,
1989). Engaging in CMT suggests that the more an individual engages in self-compassion
practices, the more they will learn these techniques and possibly lessen their chances of relapse
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and increase their lapses of abstinence. As stated previously, an additional treatment component
that has been found useful in substance use populations is mindfulness-based relapse prevention
(MBRP) (Bowen, Chawla, & Marlatt, 2010; Witkiewitz et al., 2005). These findings indicate that
MBRP can develop awareness and acceptance of thoughts, feelings, and sensations through
practicing mindfulness as a way to cope with cravings and triggers for relapse (Witkiewitz et al.,
2005). After eight weeks enrolled in a MBRP program, significant decreases have been found in
overall days of substance use, cravings, and significant increases in acceptance and acting with
awareness post-intervention (Bowen et al., 2009). With the possibilities introduced by CMT and
the findings from research examining the usefulness of MBRP, future research would be
warranted to explore the possibility of comparing rates of relapse for individuals enrolled in
either of these programs and enrolled in these programs combined.
Though the results of the present study found that self-compassion did not account for a
significant amount of additional variance in relapse risk compared to self-efficacy and trait
mindfulness, a negative association between self-compassion and relapse risk was still
supported. Considering this association was found in the primary analyses, the relationship
between self-compassion and relapse risk remains unclear. Future research should continue to
explore these variables to determine appropriate implementation of clinical treatment within
substance use treatment programs.
Lastly, drug of choice was used in the current study as a demographic item. It is
important to note the distinctions between individuals with different substance use disorders;
specifically, within the variables measured in the primary analyses. For example, Hser, Huang,
Brecht, Li, and Evans (2008) reported variation among participants with different substances of
choice (i.e., heroin, cocaine, methamphetamine). The results of their study indicated that
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individuals who used heroin used 13 to 18 days per month, individuals who used cocaine used 8
to 11 days per months, and individuals who used meth used approximately 12 days per month
(Hser et al., 2008). Though all participants in the current study were reported having a specific
substance of choice, the various substances of choice could vary in severity, likelihood of
relapse, and treatment utilization. For example, some individuals diagnosed with a cocaine use
disorder may require more mindfulness-based relapse prevention programs to lessen likelihood
of relapse, whereas individuals diagnosed with an opioid-use disorder may require more selfcompassion-oriented treatment to lessen likelihood of relapse. Perhaps future research can
explore substance of choice, self-compassion, self-efficacy, and trait mindfulness. The
exploration of these relationships can specify differences in internal variables (i.e., selfcompassion, self-efficacy, trait mindfulness) between users of different substances which may
provide information on how to effectively tailor substance use treatment.
Conclusion
The main findings of this study include the reinforcement of the relationships between
self-efficacy, trait mindfulness, and relapse risk, while also illustrating a relationship between
self-compassion and relapse risk. The finding of a relationship between self-compassion and
relapse risk warrants consideration regarding the implementation of self-compassion in addition
to mindfulness practices in applied substance use treatment settings. It is essential that these
variables continued to be researched and their relationship to substance use treatment examined
in order to initiate the implementation of these practices conjointly throughout clinical practice.
Identification of effective implementation of these practices also requires further study. As
researchers further explore evidence-based practices that may be effective with the substance use
population, mental health professionals should consider various aspects of trait mindfulness, self-
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compassion, self-efficacy and relapse risk as they continue to develop innovative treatment
programs.
Based on the current study’s findings, it would be beneficial for mental health
professionals to consider ways to teach and train the elements of self-efficacy, mindfulness, and
self-compassion practices to their clients/patients. In order to do this, further large-scale research
should be conducted to observe the effects of including self-compassion training for substance
use treatment. This research would prove to be beneficial in combination with previouslyestablished evidence-based substance use treatment programs such as those oriented towards
self-efficacy and mindfulness. We, as treatment professionals, must also understand if and how
self-compassion can be utilized to strengthen recovery and lessen the risk of relapse. If research
finds further strength to the notion of including this element in treatment settings, we must then
begin offering workshops and training seminars for those who treat individuals in substance use
treatment to gain training and experience in these areas themselves. Overall, the current findings
of the present study imply the value of including self-compassion practices into substance use
treatment to lower relapse risk for those in substance use recovery.
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Table 1

Descriptive Statistics and Correlations for Study Variables

Variable

n

M

SD

1

Relapse
risk
(AWARE)

79

96.64

25.84

-

Selfcompassion
(SCS-SF)

86

33.92

8.24

-.47**

-

Selfefficacy
(DASES)

86

88.60

19.44

-.64**

.44**

Trait
mindfulness
(FFMQ-SF)

85

76.38

12.59

-.65**

.58**

*p < .05. **p < .01.

2

3

4

.60**

-

-
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Table 2

Hierarchical Regression Results for Relapse Risk
Variable

B

95% CI for B
LL
UL

SE B

β

Step 1
Constant
174.50*** 152.87 196.13 10.86
Self-efficacy
-.87***
-1.10
-.63
0.12
-.65***
Step 2
Constant
212.57*** 187.03 238.11 12.82
Self-efficacy
-.52***
-.78
-.26
0.13
-.39***
Trait mindfulness
-.90***
-1.29
-.50
0.20
-.44***
Step 3
Constant
212.75*** 187.04 238.45 12.90
Self-efficacy
-.51***
-.78
-.24
0.13
-.38***
Trait mindfulness
-.86***
-1.30
-.41
0.23
-.42***
Self-compassion
-.13
-.76
.49
0.31
-.04
Note. CI = confidence interval; LL = lower limit; UL = upper limit.
*p < .05. **p < .01. ***p < .001.

R2

ΔR2

.42

.42***

.54

.13***

.54

.00

ROLES IN RELAPSE RISK

83

Table 3
Demographic Characteristics of Participants
Characteristic
Gender
Male
Female
Transgender M2F
Ethnic/Racial Identity
African American or Black
Hispanic or Latino/a
Caucasian American or White
Biracial or Multicultural American
Primary Drug of Choice
Alcohol
Crack
Heroin
Methamphetamine
Cocaine
Amphetamines “Uppers”
Benzodiazepines “Downers”
Marijuana
Other
Frequency of Group Participation
None
Daily
Weekly
Bi-Weekly
Multiple Days Per Week

Full sample
n

%

44
42
1

50.6
48.3
1.1

6
1
77
2

7
1.2
89.5
2.3

7
6
29
18
4
3
4
4
12

8
6.9
33.3
20.7
4.6
3.4
4.6
4.6
13.8

1
27
30
15
5

1.3
34.6
38.5
19.2
6.4

Note. N = 87. Participants were on average 35.2 years old (SD = 8.6).
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Table 4
Means and Standard Deviations for Demographic Characteristics
Characteristic
Age
Times in Treatment
Number of Relapses in
Past 6 Months
Current Treatment
Duration (Days)
Household Income

M
35.2
4.6
8.1

Mdn
34
3
2

Mode
29
1
0

SD
8.6
3.9
23.2

Range
19-62
1-18
0-180

398.6

60

60

771

2-3650

22633.5

12000

0

28337.9

0-130000
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Table 5
Summary of Multiple Regression Analyses for Predictors of Relapse Risk

Variables

Model 1
Control Variables

Model 2
Control Variables + SelfCompassion

R2 = .14, ΔR2 = .14
(SE = 25.06)

R2 = .36, ΔR2 = .23
(SE = 21.66)

Model 3
Control Variables + SelfCompassion + SelfEfficacy
R2 = .56, ΔR2 = .18
(SE = 18.52)

Model 4
Control Variables + SelfCompassion + SelfEfficacy + Trait
Mindfulness
R2 = .61, ΔR2 = .06
(SE = 17.36)

B

SE B

β

B

SE B

β

B

SE B

Β

B

SE B

β

SelfCompassion

--

--

--

-1.45

.31

**-.49

-.66

.31

*-.22

-.18

.33

-.06

Self-Efficacy

--

--

--

--

--

--

-.68

.14

**-.52

-.48

.15

*-.37

Trait
Mindfulness

--

--

--

--

--

--

--

--

--

-.76

.25

*-.38

Race

-13.42

11.03

-.15

-9.79

9.57

-.11

-.60

8.40

-.01

1.34

7.90

.02

Gender

-5.02

6.28

-.10

-6.45

5.44

-.12

-7.64

4.66

-.15

-3.78

4.55

-.07

Age

-1.07

.37

-.35

-.79

.33

*-.26

-.55

.29

-.18

-.57

.27

-*.19

.08

2.12

2.38

.09

.98

2.05

1.00

1.92

.04

.52

Group
1.82
2.75
Participation
Note. n = 65; *p < .05; **p < .01
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Table 6
Trait Mindfulness as a Mediator between Predictor of Self-Compassion and Outcome of Relapse Risk

Variables

Model 1
Self-Compassion on
Relapse Risk

Model 2
Self-Compassion on
Trait Mindfulness

Model 3
Trait Mindfulness on
Relapse Risk

R2 = .222 (SE = 22.93)

R2 = .337 (SE = 10.32)

R2 = .418 (SE = 19.93)

Model 4
Self-Compassion and
Trait Mindfulness on
Relapse Risk
R2 = .431 (SE = 19.84)

B
Self-.1.46
Compassion
Trait
-Mindfulness
Note. **p < .01

SE B

Β

B

SE B

β

B

SE B

Β

B

SE B

β

.32

**-.47

.88

.14

**.58

--

--

--

-.43

.34

-.14

--

--

--

--

--

-1.30

.18

**-.65

-1.13

.22

**-.56
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Figure 1
Mediation Model with Self-Compassion, Trait Mindfulness, and Relapse Risk
Mediator:
β = .580

Trait Mindfulness

p < .001

p < .001

Predictor Variable:
Self-Compassion

β = -.647

Outcome:
β = -.471

Relapse Risk

p < .001
β = -.139
p =.122

Figure 1. Model testing mediation of the relationship between self-compassion and relapse risk
by trait mindfulness. Values in parentheses represent the standardized relation of selfcompassion to relapse risk after controlling for trait mindfulness.
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APPENDICES

Appendix A: Drug Avoidance Self-Efficacy Scale
The following 16 situations may trigger someone’s intention to use substances. Please select a
response for each question, indicating what you would be likely to do in each situation. Use the rating
scale below.
This questionnaire is used for project evaluation only. All information will be kept confidential.
Substance use refers to the use of prohibited or legal psychotropic substances e.g. ketamine,
marijuana, “ice”, ecstasy, alcohol, cough medicine, thinner etc. without doctor’s prescription.
7

6

5

Certainly
Very likely
Probably
yes
yes
yes
1. Imagine that you are going to a party
7
where you will meet new people. You feel
that drug/alcohol use will relax you and
make you more confident. Could you
avoid substance use?

2. Imagine that you have just blown a good
job, you are home alone and depressed.
Would you give in to the urge to use
substances which are in the house?
3. Imagine that you are home with a loved on
one, and feeling angry after a fight.
You want to make up, but at the same time
you want to get stoned/loaded.
Could you resist the urge to use substances?

4

3

Really can’t
say
6
5
4

7

6

Probably
no
3
2
1

5

4

7

3

6

2

1

Very likely
no

Certainly
no

2

5

4. Imagine that you are feeling good and have
7
6
5
4
3
2
no responsibilities for a couple of days. The
only thing you see against getting a bit
stoned/loaded is that you have promised
yourself you would go straight for 2 months,
and you still have 3 weeks to go. Would you
use?
5. Imagine it is late, you cannot sleep and 7
6
5
4
3
2
1
drugs/alcohol are available in the house. You have
decided not to use. Could you resist the
urge to use drugs/alcohol to help you
get to sleep?

1

4

3

1

2

1
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7

6. Imagine that a new job is starting
tomorrow, you are going out with friends and
expecting a good time. Could you resist the
urge to celebrate with substances?
7. Imagine that you are home
with your loved
one, and very angry after a fight.
You are tempted to get back at
your partner by getting stoned/loaded.
Would you give in to the temptation?

7

6

Certainly
yes

Very likely yes

6

5

7

5

5

1

4

3

6

5

2

1

2

1

Probably no Very likely no

5

4

4

3

10. Imagine that you are at a party and feeling
uptight. Most people seem to be having a
good time. You are tempted to use drugs or
alcohol to loosen up. Would you?
11. Imagine that you promised yourself to
stay straight for 2 months but you have just
blown your 5 week record with one hit
or drink. Would this situation lead you
to take a second one?

7

6

5

12. Imagine that you had managed to stay
straight for a near record time, but last night
you blew it. Because of last night you are
feeling weak. Would you use tonight?
13. Imagine that you are home alone and
depressed. Could you resist the urge to go
out and seek substances?

7

6

5

6

5

4

7

7

2

3

7
6

3

6

4

Probably yes Really can’t say

8. Imagine that a very important relationship
has just ended, and you are very depressed
Would you give in to the urge to use
substances?
9. Imagine that you have run into 2 friends 7
who are celebrating a win at horse racing
with substances. Could you resist their
urging to join them in substance use?

4

3

2

4

6

3

4

2

4

3

2

1

1

5

3

2

Certainly no

3

2

1

1

2

1

1

ROLES IN RELAPSE RISK

102

14. Imagine that a good friend has accused
you of being insensitive. Now you are feeling
hurt and tempted to use substances. Could
you resist?
15. Imagine that a good friend is feeling
miserable. He wants you to join him
in heavy discussion and substance use to
pick his spirits up. Could you resist the
urge to use substances?

7

16. Imagine that you are home alone; it is a
dull weekend with nothing in particular to look
forward to. You are bored. Would you give in
to the urge to get stoned/loaded?

7

6

5

7

6

4

6

5

3

5

4

2

4

3

1

3

2

2

1

1
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Appendix B: Five Facet Mindfulness Questionnaire-Short Form
Below is a collection of statements about your everyday experience. Using the 1–5 scale below,
please indicate, in the box to the right of each statement, how frequently or infrequently you have
had each experience in the last month (or other agreed time period). Please answer according to
what really reflects your experience rather than what you think your experience should be.
never or
not often
sometimes true
very rarely true true
sometimes not true
1
2
3

often
true
4

very often
or always true
5

1

I’m good at finding the words to describe my feelings

DS

2

I can easily put my beliefs, opinions, and expectations into words

DS

3

I watch my feelings without getting carried away by them

NR

4

I tell myself that I shouldn’t be feeling the way I’m feeling

/NJ

5

it’s hard for me to find the words to describe what I’m thinking

/DS

6

I pay attention to physical experiences, such as the
wind in my hair or sun on my face

OB

7

I make judgments about whether my thoughts are good or bad.

/NJ

8

I find it difficult to stay focused on what’s happening in the present moment

/AA

9

when I have distressing thoughts or images, I don’t
let myself be carried away by them

NR

10

generally, I pay attention to sounds, such as clocks ticking, birds
chirping, or cars passing

OB

11

when I feel something in my body, it’s hard for me
to find the right words to describe it

/DS

12

it seems I am “running on automatic” without
much awareness of what I’m doing

/AA

13

when I have distressing thoughts or images, I feel calm soon after

NR
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14

I tell myself I shouldn’t be thinking the way I’m thinking

/NJ

15

I notice the smells and aromas of things

OB

16

even when I’m feeling terribly upset, I can find a way to put it into words

DS

17

I rush through activities without being really attentive to them

/AA

18

usually when I have distressing thoughts or images I can
just notice them without reacting

NR

PTO.
never or
not often
very rarely true true
1
2

sometimes true
often
very often
sometimes not true true
or always true
3
4
5

19

I think some of my emotions are bad or
inappropriate and I shouldn’t feel them

/NJ

20

I notice visual elements in art or nature, such as colors, shapes,
textures, or patterns of light and shadow

OB

21

when I have distressing thoughts or images, I just
notice them and let them go

NR

22

I do jobs or tasks automatically without being aware of what I’m doing

/AA

23

I find myself doing things without paying attention

/AA

24

I disapprove of myself when I have illogical ideas

/NJ
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Appendix C: Self-Compassion Scale-SF
Please read each statement carefully before answering. To the left of each item, indicate how
often you behave in the stated manner, using the following scale:
Almost
never
1

2

3

4

Almost
always
5

___1. When I fail at something important to me I become consumed by feelings of inadequacy.
_____2. I try to be understanding and patient towards those aspects of my personality I don’t
like.
_____3. When something painful happens I try to take a balanced view of the situation.
_____4. When I’m feeling down, I tend to feel like most other people are probably happier than I
am.
_____5. I try to see my failings as part of the human condition.
_____6. When I’m going through a very hard time, I give myself the caring and tenderness I
need.
_____7. When something upsets me I try to keep my emotions in balance.
_____8. When I fail at something that’s important to me, I tend to feel alone in my failure
_____9. When I’m feeling down I tend to obsess and fixate on everything that’s wrong.
_____10. When I feel inadequate in some way, I try to remind myself that feelings of inadequacy
are shared by most people.
_____11. I’m disapproving and judgmental about my own flaws and inadequacies.
_____12. I’m intolerant and impatient towards those aspects of my personality I don’t like.
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Appendix D: Advanced Warning of Relapse Scale

Please read the following statements and for each one circle a number, from 1 to 7, to
indicate how much this has been true for you recently. Please circle one and only one
number for every statement.
Never

Rarely

Sometimes

Fairly
often

Often

Almost
always

Always

1. I feel nervous or unsure of my ability to
stay clean of alcohol and/or drugs.

1

2

3

4

5

6

7

2. I have many problems in my life.

1

2

3

4

5

6

7

3. I tend to overreact or act impulsively.

1

2

3

4

5

6

7

4. I keep to myself and feel lonely.

1

2

3

4

5

6

7

5. I get too focused on one area of my
life.

1

2

3

4

5

6

7

6. I feel blue, down, listless, or depressed.

1

2

3

4

5

6

7

7. I engage in wishful thinking.

1

2

3

4

5

6

7

8. The plans that I make succeed.

1

2

3

4

5

6

7

9. I have trouble concentrating and prefer
to dream about how things could be.

1

2

3

4

5

6

7

10. Things don’t work out well for me.

1

2

3

4

5

6

7

11. I feel confused.

1

2

3

4

5

6

7

12. I get irritated or annoyed with my
friends.

1

2

3

4

5

6

7

ROLES IN RELAPSE RISK

107

13. I feel angry or frustrated.

1

2

3

4

5

6

7

14. I have good eating habits.

1

2

3

4

5

6

7

15. I feel trapped and stuck, like there is
no way out.

1

2

3

4

5

6

7

16. I have trouble sleeping.

1

2

3

4

5

6

7

17. I have long periods of serious
depression.

1

2

3

4

5

6

7

18. I don’t really care what happens.

1

2

3

4

5

6

7

19. I feel like things are so bad that I
might as well use substances.

1

2

3

4

5

6

7

20. I am able to think clearly.

1

2

3

4

5

6

7

21. I feel sorry for myself.

1

2

3

4

5

6

7

22. I think about using substances.

1

2

3

4

5

6

7

23. I lie to other people.

1

2

3

4

5

6

7

24. I feel hopeful and confident.

1

2

3

4

5

6

7

25. I feel angry at the world in general.

1

2

3

4

5

6

7

26. I am doing things to stay clean of
alcohol and/or drugs.

1

2

3

4

5

6

7
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27. I am afraid that I am losing my mind.

1

2

3

4

5

6

7

28. I am using alcohol and/or drugs out of
control.

1

2

3

4

5

6

7
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Appendix E: Substance Abuse Relapse and Demographics
1. Which of the following describes your gender identity? (Circle One of the Following)
• Male
• Female
• TransM2F
• TransF2M
• Other: ___________
2. What is your current age? _______

3. Which of the following best represents your ethnic/racial identity? (Circle One of the
Following)
• African American or Black
• Asian American or Pacific Islander
• American Indian or Native American or Alaskan Native
• Arabic American or Middle Eastern
• Hispanic or Latino/a
• East Indian or Indian American
• Caucasian American or White
• Biracial or Multiracial American
• Other: ____________

4. What is your primary drug of choice? (Please circle ONE of the following)
• Alcohol
• Crack
• Heroin
• Methamphetamine
• Cocaine
• Amphetamines “Uppers”
• Benzodiazepines “Benzos”
• Marijuana
• LSD
• PCP
• Other: ___________
5. By your estimate, how many times would you say you have been in substance abuse
treatment? __________
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6. By your estimate, how many times would you say you have relapsed in the past 6 months?
(Must have had 1 week of continued sobriety before using)
____________________
7. How long have been in your current treatment?
_______________________
8.

By your estimate, what is your household income?

______________________
9. How often do you participate in group?

_______________________
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Appendix F: Recruitment Letter

Dear Participant,

This letter is a request for you to take part in a research project to assess how internal factors
affect relapse risk among individuals recovering from substance use. This project is being
conducted by Jonathan Nauser, doctoral candidate in the Department of Counseling,
Rehabilitation Counseling, and Counseling Psychology at WVU under the supervision of Dr.
Monica Leppma, Associate Professor in the College of Education and Human Services. Your
participation in this project is greatly appreciated and will take approximately 20-30 minutes to
fill out the attached questionnaire.
Your involvement in this project will be kept as confidential as legally possible. All data will be
reported in the aggregate. You must be 18 years of age or older to participate. I will not ask any
information that should lead back to your identity as a participant. Your participation is
completely voluntary. You may skip any question that you do not wish to answer and you may
discontinue at any time. Your treatment will not be affected if you decide either not to participate
or to withdraw. West Virginia University's Institutional Review Board acknowledgement of this
project is on file. Upon completion of the survey packet, you will be rewarded a $5.00 Sheetz
gift card for your participation.
I hope that you will participate in this research project, as it could be beneficial in understanding
the impact of internal factors on relapse risk in individuals recovering from substance use. Thank
you very much for your time. Should you have any questions about this letter or the research
project, please feel free to contact Monica Leppma at (304) 293-0540 or by e-mail at
monica.leppma@mail.wvu.edu.

Thank you for your time and help with this project.

Sincerely,

Jonathan Nauser MS
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Appendix E: Informed Consent Form
Human Research Protocol
Only Minimal Risk Consent Form
(With HIPAA)

Only Minimal Risk
Consent Information and HIPAA Form
Principal Investigator

Monica Leppma, Ph.D.

Department

Counseling, Rehabilitation Counseling, and Counseling Psychology

Protocol Number

Click here to enter text.

Study Title
The Roles of Self-Efficacy, Trait Mindfulness, and Self-Compassion in Relapse:
Assessing Variance Explained for Relapse Risk
Co-Investigator(s)

Jonathan Nauser, MS

Sponsor (if any)

N/A

Contact Persons
If you have any questions, concerns, or complaints about this research, you can contact Jonathan Nauser via
email at jwn0003@mix.wvu.edu.
In the event you experience any side effects or injury related to this research, you should contact Dr. Leppma at
(304) 293-0540.
For information regarding your rights as a research subject, to discuss problems, concerns, or suggestions
related to the research, to obtain information or offer input about the research, contact the Office of Research
Integrity and Compliance at (304) 293-7073.
In addition, if you would like to discuss problems, concerns, have suggestions related to research, or would like
to offer input about the research, contact the Office of Research Integrity and Compliance at 304-293-7073.

Introduction
You have been asked to participate in this research study, which has been explained to you by Jonathan Nauser.
This study is being conducted by Jonathan Nauser & Monica Leppma in the Department of Counseling,
Rehabilitation Counseling, and Counseling Psychology at West Virginia University.

Purpose(s) of the Study
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The purpose of this study is to explore the personal factors that contribute to relapse risk among individuals
recovering from substance abuse.

Description of Procedures
This study involves filling out a packet of questionnaires and will take approximately 20-30 minutes for you to
complete. You will be asked to fill out questionnaires regarding your self-efficacy, trait mindfulness, selfcompassion, relapse risk, drug use history, and demographics. This will take approximately 20-30 minutes. You
do not have to answer all the questions. You will have the opportunity to see the questionnaire before signing
this consent form.

Discomforts
There are no known or expected risks from participating in this study, except for the mild frustration associated
with answering the questions.

Alternatives
You do not have to participate in this study.

Benefits
You may not receive any direct benefit from this study. The knowledge gained from this study may eventually
benefit others.

Financial Considerations
Each participant that agrees to participate in the study will be rewarded 1 of 100 $5.00 Sheetz gift cards. If you
withdraw before the end of the study, you will not be rewarded one of the gift cards. If you successfully
complete the study, you will then be rewarded 1 of 100 $5.00 Sheetz gift cards.

Confidentiality
Any information about you that is obtained as a result of your participation in this research will be kept as
confidential as legally possible. Your research records and test results, just like hospital records, may be
subpoenaed by court order or may be inspected by the study sponsor or federal regulatory authorities without
your additional consent.
Audiotapes or videotapes will be kept locked up and will be destroyed as soon as possible after the research is
finished.
In any publications that result from this research, neither your name nor any information from which you might
be identified will be published without your consent.

HIPAA
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We know that information about you and your health is private. We are dedicated to protecting the privacy of
that information. Because of this promise, we must get your written authorization (permission) before we may
use or disclose your protected health information or share it with others for research purposes.
You can decide to sign or not to sign this authorization section. However, if you choose not to sign this
authorization, you will not be able to take part in the research study. Whatever choice you make about this
research study will not have an effect on your access to medical care.

Persons/Organizations Providing the Information
Patient

Persons/Organizations Receiving the Information
•
The research site(s) carrying out this study. This includes WVU. It also includes each site’s research
staff and medical staff.
•
The members and staff of any Institutional Review Board (IRB) that oversees this research study.

The Following Information Will Be Used
Information that is collected during the study such as: history, demographic data, and study forms.

The Information is Being Disclosed for the Following Reasons
•

Publication of study results (without identifying you)

You May Cancel this Authorization at Any Time by Writing to the Principal Investigator
Monica Leppma PhD monica.leppma@mail.wvu.edu
If you cancel this authorization, any information that was collected already for this study cannot be withdrawn.
Once information is disclosed, according to this authorization, the recipient may redisclose it and then the
information may no longer be protected by federal regulations.
You have a right to see and make copies of your medical records. You will not be able to see or copy your records
related to the study until the sponsor has completed all work related to the study. At that time you may ask to see
the study doctor’s files related to your participation in the study and have the study doctor correct any information
about you that is wrong.
This authorization will expire at the end of the study unless you cancel it before that time.

Voluntary Participation
Participation in this study is voluntary. You are free to withdraw your consent to participate in this study at any
time.
Refusal to participate or withdrawal will not affect your treatment and will involve no penalty to you. Refusal to
participate or withdrawal will not affect your future care at West Virginia University.
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In the event new information becomes available that may affect your willingness to participate in this
study, this information will be given to you so that you can make an informed decision about whether or
not to continue your participation.
You have been given the opportunity to ask questions about the research, and you have received answers
concerning areas you did not understand.
Upon signing this form, you will receive a copy.
I willingly consent to participate in this research.

Signatures
Signature of Subject
______________________________________________________________________________
Printed Name
Date
Time
______________________________________________________________________________
The participant has had the opportunity to have questions addressed. The participant willingly
agrees to be in the study.
Signature of Investigator or Co-Investigator
______________________________________________________________________________
Printed Name
Date
Time
______________________________________________________________________________

